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Abstract: Die drei Checkpoint-Proteine Rad9, Rad1 und Hus1 spielen eine wichtige Rolle bei der Kon-
trolle der replizierten DNA an Kontrollpunkten (checkpoints) des Zellzyklus. Diese werden als Folge eines
DNA-Schadens aktiviert, verlangsamen oder stoppen die DNA- Replikation und koordinieren die DNA-
Reparaturmechanismen. Wenn diese Kontrollmechanismen der Zelle versagen, kann dies zur Instabilität
des Genoms führen und damit letzten Endes zur Entwicklung von Krebs beitragen. Für biochemische
Untersuchungen und Strukturanalysen von Rad9, Rad1 und Hus1 sind lösliche und funktionell aktive
Proteine erforderlich. Es ist jedoch bekannt, dass diese drei Checkpoint-Proteine in E.coli ausseror-
dentlich schwierig zu exprimieren sind und bisher nur wenige und unvollständige Daten darüber pub-
liziert wurden. Im Rahmen der vorliegenden Dissertation wurden verschiedene E. coli Stämme getestet,
hauptsächlich spezielle E.coli BL21-Codon Plus Stämme, welche gewisse Aminosäure-Codons in hohem
Masse exprimieren. Ausserdem wurden unterschiedliche Fusionspartner und Expressionsbedingungen für
die drei Checkpoint-Proteine getestet, um auf empirischem Weg optimale Bedingungen für deren bak-
terielle Produktion zu etablieren. Zusammenfassend kann ausgesagt werden, dass E.coli BL21-Codon
Plus Stämme sich eignen, um genügende Mengen der zwei Checkpoint-Proteine Rad1 und Rad9, sowie in
beschränktem Ausmass Hus1 zu isolieren, wobei deren korrekte Faltung durch deren gegenseitige spez-
ifische und direkte Interaktion in vitro gezeigt werden konnte. The human checkpoint proteins Rad9,
Rad1 and Hus1 are three DNA quality control proteins that play a critical role in cell cycle checkpoint
signalling pathways. These checkpoints are activated due to DNA damage, slow down cell cycle progres-
sion and coordinate DNA repair. Failure of this cell cycle surveillance mechanism can cause genomic
instability which could eventually lead to cancer formation in mammals. Soluble and functionally active
proteins are required for biochemical and structural analysis of Rad9, Rad1 and Hus1. It is known that
these three checkpoint proteins are extraordinarily difficult to express in E.coli and only little and in-
complete data was collected on their bacterial expression. In this thesis different E.coli-strains were used
focussing on special E.coli BL21- Codon Plus strains, which selectively express certain amino-acids in
abundance. Furthermore, different fusion partners and expression conditions were tested for each indi-
vidual checkpoint protein in order to empirically establish optimised expression conditions. In summary,
E.coli BL21-Codon Plus strains are a suitable system for the production of the two checkpoint proteins
Rad1 and Rad9, and to some extent also of Hus1, whereas their proper folding was shown by their direct
and specific interaction in vitro.
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0. Abbreviations and explanations 
A600 Optical density, measured at 600nm wavelength 
arg, ile, leu, pro Amino-acids: the three letter code is used 
ATP Adenosine-triphosphate 
AvaI, BamHI, EcoRV DNA restriction enzymes 
BSA Bovine serum albumine 
cDNA Complementary DNA: single-stranded DNA 
complementary to a RNA 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
ECL Detection System A non-isotopic method for detecting protein 
immobilised on membranes 
E.coli Escherichia coli 
EDTA Ehtylendiamintetraacetate 
FPLC Fast protein, peptide and polynucleotide liquide 
chromatography 
GST Glutathione-S-transferase 
GSTrap Prepacked Glutathione Sepharose columns for one-
step purification of GST-fusion proteins or other 
Glutathione binding proteins 
HDAC1 Member of the histone deacetylase family 
(His)6-protein 6xHis-tagged protein 
HiTrap Q Anion exchange column, Q Sepharose High 
Performance 
HRP Horseradish peroxidase 
IPTG Isopropyl-β-D-thiogalactopyranoside 
LB Luria-Bertani Medium: liquid bacterial medium 
consisting of bacto-tryptone, bacto-yeast extract 
and NaCl 
LMW Low molecular weight markers 
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MBP Maltose-binding protein 
NP-40 Nonidet P 40 
PBS Phosphate-buffered saline 
PCNA Proliferating cell nuclear antigen 
PCR Polymerase chain reaction 
 
pGEX-4T-3, pREP4, pMalc-2E,  Different bacterial expression vectors for 
pRSET B, pET 24a+ heterologues protein production 
 
pI Isoelectric point 
PMSF Phenylmethylsulfonyl fluoride 
Rad17, Rad9, Rad1 and Hus1 DNA quality control proteins, checkpoint proteins 
RF-C Replication factor C 
S. cerevisiae Saccharomyces cerevisiae 
SDS Sodium dodecyl sulfate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
S. pombe Schizosaccharomyces pombe 
TBS Tris-buffered saline 
TBST Tris buffered saline with additional Tween20 
tRNA Transfer Ribonucleic acid 
 
Units:  
hr/hrs Hour/hours 
kDa Molecular mass; 1000 Da = 1 kDa 
psi Pounds per square inch  
RCF Relative centrifugal force, also referred to as g-
force. It is relative to the earth's gravitational force 
and is identified as xg (times gravity) or RCF 
rpm Rotor speed in revolutions per minute 
v/v Volume per volume; percentage concentration in 
ml per 100ml fluid 
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1. Introduction and Problem 
The DNA of mammals is constantly under pressure of the environment, thus leading to 
alteration in the DNA double helix. A mammalian cell has about 10,000 damaging events 
per day. On the other hand, DNA has to be very stable to maintain the genetic 
information from generation to generation. It is therefore not surprising that nature has 
developed many mechanisms to circumvent these problems. They include direct DNA 
repair, base excision repair and nucleotide excision repair. Moreover, cell cycle 
checkpoint control guarantees that cells entering or leaving DNA replication do not 
duplicate damaged DNA thus leading to mutations that might end up in alterations of the 
cellular phenotype (e.g. to cancer). 
Rad9, Rad1 and Hus1 are three human proteins that play a critical role in cell cycle 
checkpoint signalling pathways. These checkpoints are activated after DNA damage and 
allow the slowing down of cell cycle progression and coordinate DNA repair. In recent 
studies it has been shown that Rad9, Rad1 and Hus1 interact in a head-to-tail manner 
(Burtelow et al., 2001). Supported by molecular modelling studies these observations 
suggest a model in which Rad9, Rad1 and Hus1 form a stable, heterotrimeric ring similar 
to PCNA. This clamp could be loaded onto DNA by a clamp loader that recognizes DNA 
damage. Once loaded, this complex could be a platform for signalling and repair 
molecules (Dahm and Hubscher, 2002; Cai et al., 2000; Caspari et al., 2000; Venclovas 
and Thelen, 2000) (Figure 1). 
These proteins are however difficult to express in bacteria. For expression of recombinant 
protein E.coli is normally the first choice, because it is quick, cheap and provides high 
yields of expression. Some eukaryotic proteins however do not fold properly in bacteria 
and form insoluble aggregates. Other problems working with bacteria include cell 
toxicity, inefficient translation, improper processing or post-translational modifications. 
Some of these problems can often be solved by testing different tagged proteins and 
E.coli strains, optimising expression conditions by lower growth temperature and varying 
the IPTG-concentration, cell density (A600) and induction period. In this thesis, the 
bacterial expression of the three human checkpoint proteins Rad9, Rad1 and Hus1 was 
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successfully optimised by using different E.coli strains and testing several fusion proteins 
at different expression conditions. 
 
 
Figure 1. PCNA-like trimer consisting of Hus1, Rad1 and Rad9. It has been shown that Rad9, Rad1 and 
Hus1 interact in a head-to-tail manner and molecular modelling studies support a model in which Rad9, 
Rad1 and Hus1 form a stable, heterotrimeric ring similar to PCNA. Previously published data suggests a 
model, in which a Rad17/RF-C complex functions as a sensor or signal transducer. It binds to the 
Rad9/Hus1/Rad1 (9-1-1) complex and enables it to interact with PCNA. PCNA could provide 
communication between replication checkpoint control, DNA repair and the resumption of DNA 
replication (from Dahm and Hübscher, 2002). 
1.1. Function of the three checkpoint proteins Rad9, Rad1 and Hus1 
DNA damage provokes multiple cellular responses including the slowing down of cell 
cycle progression. The eukaryotic cell cycle consists of a number of tightly regulated 
events to ensure that DNA replication and cell division occur with high fidelity. In the 
presence of damaged or incompletely replicated DNA, the DNA damage (G2) and DNA 
replication (S-phase) checkpoints arrest eukaryotic cells at the G2/M transition (al-
Khodairy et al., 1994; al-Khodairy and Carr, 1992; Enoch et al., 1992; Rowley et al., 
1992; Enoch and Nurse, 1990; Weinert and Hartwell, 1990; Weinert and Hartwell, 1988), 
thus providing time to repair damage or complete replication before the cell enters into 
mitosis. In S. pombe six checkpoint genes have been identified called Rad1, Rad3, Rad9, 
Rad17, Rad26 and Hus1 (al-Khodairy et al., 1994; al-Khodairy and Carr, 1992; Enoch et 
al., 1992; Rowley et al., 1992). They are required for both G2 and S-phase checkpoint 
controls. Checkpoint rad-mutants are unable to block mitotic entry in response to DNA-
5´
hRAD17
Rad9/Hus1/Rad1
PCNA
5´
1
1
9 RPA
RF-C
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damaging agents or transient inhibition of DNA synthesis (al-Khodairy et al., 1994; al-
Khodairy and Carr, 1992; Enoch et al., 1992; Rowley et al., 1992). Mitotic entry is 
regulated by dephosphorylation of the tyrosin-15 residue of the cyclin-dependent kinase 
Cdc2 (O'Connell et al., 1997; Rhind et al., 1997; Enoch and Nurse, 1990) (Figure 2).  
Phosphorylation/dephosphorylation of this residue is controlled primarily by the Cdc25 
phosphatase and the Wee1 protein kinase, respectively. The activity of these two 
enzymes is regulated in turn by the kinases Chk1 (for Cdc25) and Cds1 (for Wee1) 
(Furnari et al., 1997; Walworth et al., 1993). Chk1 is part of the G2 checkpoint and is 
activated after DNA damage. It phosphorylates Cdc25, which thereby prevents Cdc2-
dephosphorylation and mitotic entry (Furnari et al., 1997; Walworth et al., 1993). The S-
phase checkpoint, on the other hand, is controlled by the activation of Cds1. It leads to 
phosphorylation of Wee1, which is able to phosphorylate Cdc2 and inhibit mitotic entry 
(Boddy et al., 1998). The checkpoint rad proteins are placed upstream of the Cdc2 
regulators in the signal transduction pathway because the checkpoint induced 
phosphorylation of Chk1 and Cds1 is dependent on the presence of all the checkpoint rad 
proteins (Lindsay et al., 1998; Walworth and Bernards, 1996). 
Many of the genes involved in G2 checkpoint pathways are conserved in the eukaryotic 
kingdom between yeast and humans (Table 1), suggesting that yeast G2 checkpoint 
signalling mechanisms may be similar to that of humans (Kostrub et al., 1998; Parker et 
al., 1998; Udell et al., 1998; Cimprich et al., 1996; Lieberman et al., 1996). 
Table 1. G2 checkpoint proteins in two yeasts and human 
S. pombe S. cerevisiae Homo sapiens 
Rad1 RAD17 hRad1 
Rad3 MEC1 ATR/FRP1 
Rad9 DDC1 hRad9 
Rad17 RAD24 hRad17 
Rad26 ? ? 
Hus1 ? hHus1 
Chk1 CHK1 Chk1 
Cds1 RAD53 Chk2 
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Figure 2. DNA damage (G2) and DNA replication (S-Phase) checkpoint control. Schematic 
representation of DNA damage (G2) and DNA replication (S-Phase) checkpoint, which arrest eukaryotic 
cells at the G2/M transition in the presence of damaged or incompletely replicated DNA to provide time for 
repair before the cell enters into mitosis. The checkpoint rad proteins are placed upstream of the Cdc2 
regulators Chk1 and Cds1. The time declaration relates to mammalian cells in cell culture. For details see 
text. 
 
Molecular modelling studies were used to propose functions for Rad9, Rad1, Hus1 and 
Rad17 (Cai et al., 2000; Caspari et al., 2000; Venclovas and Thelen, 2000). They support 
the model that Rad9, Rad1 and Hus1 form a heterotrimeric, PCNA-like clamp. PCNA is 
a homotrimeric ring that is loaded onto DNA by a clamp loader, replication factor C (RF-
C) in an ATP-dependent manner (Hubscher et al., 2002; Mossi and Hubscher, 1998). 
Once loaded, PCNA encircles the DNA as a sliding clamp and tethers replication 
proteins, including DNA polymerase δ. Rad9, Rad1 and Hus1 have been shown to 
interact by immunoprecipitation and by yeast-two-hybrid analysis (Caspari et al., 2000; 
Hang and Lieberman, 2000; St Onge et al., 1999; Volkmer and Karnitz, 1999). Following 
DNA damage, these three proteins were converted to an extraction-resistant, chromatin 
bound complex. By size-exclusion chromatography it has been shown that they interact 
in a head-to-tail manner, supporting the model of a circular organisation of these three 
proteins. Additionally, the S. cerevisiae homologue of Rad17 has been shown to interact 
with the four small subunits of RF-C in a stable complex (Green et al., 2000). 
A: S-phase 
control
Wee 1 Cdc25
Chk1Cds1
B:  G2-phase controlA:  S-phase control
DNA damage
PP
Cdc2 - tyr 15      
P
P
P
Incomplete DNA 
replication
B:
G2-phase 
control
G1
S
G2
M
1h
3h
12h
8h
Rad1, Rad9, Hus1, Rad17
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Furthermore, Rad17 interacts with Rad9, Rad1 and Hus1 in a manner that requires an 
intact Rad17-ATP-binding domain (Rauen et al., 2000).  
All these data supports a model in which the four small subunits of RF-C form a complex 
with Rad17, which could act as a clamp-loader that recognizes DNA damage (Figure 1). 
Conformational changes in the subunits of the Rad17/RF-C complex associated with 
ATP-binding/hydrolysis could break the heterotrimeric ring and load it onto DNA. Once 
loaded, this Rad9-Rad1-Hus1-complex could be a platform to allow other enzymes to 
repair DNA lesions in a processive manner. The exact structure of the Rad9-Rad1-Hus1 
interaction can only be confirmed by structural analysis of the purified complex. 
Additionally, each of these three checkpoint proteins could have an additional cellular 
role independent of this complex formation. 
1.2. Expression of recombinant proteins in E.coli: general problems 
Among the many systems available for heterologous protein production, the gram-
negative bacterium E.coli remains one of the most attractive, firstly because of its ability 
to grow rapidly and at high density on inexpensive substrates, secondly due to its well 
characterized genetics and thirdly because of the large number of cloning vectors and 
mutant host strains available. With careful choice of host strains, vectors and growth 
conditions, most recombinant proteins can be cloned and expressed at high levels. 
However, mainly eukaryotic gene products can accumulate as insoluble aggregates in 
E.coli, so called inclusion bodies that lack functional activity. Other problems may 
include cell toxicity, inefficient translation, improper processing or posttranslational 
modifications. 
1.2.1. Solubility problems 
For biochemical and structural studies, it is important to obtain soluble and functionally 
active proteins, whereas for antibody-production, the antigen protein can be expressed 
either in native or denatured form. The conditions for optimal expression of individual 
proteins must be determined empirically. Optimal growth and expression conditions 
should be established with small-scale culture before large-scale protein purification is 
attempted in order to judge the effects of various growth conditions on expression levels 
 11 
and solubility of recombinant proteins. The intracellular protein content is often a balance 
between the amount of soluble protein in the cells, the formation of inclusion bodies and 
protein degradation. Therefore, a time-course analysis of the expression level is useful to 
check the soluble and insoluble fractions at various times after induction and to establish 
the optimal induction period. By monitoring the cell growth before and especially after 
induction, the toxicity of an expressed protein can also be judged.  
A reduction of the growth temperature following induction may be helpful to get higher 
levels of a soluble protein. Growth temperature affects both expression level and protein 
solubility and lower temperatures will reduce expression levels leading to a higher 
amount of soluble protein. By reducing the IPTG-concentration, the expression level can 
also be kept low. Alternatively, the culture can be induced at a higher cell density (optical 
density/ A600) and the expression period can be reduced to a minimum. Furthermore, it 
may be reasonable to test different E.coli strains with different genetic background, 
because certain strains tolerate some proteins better than others and allow higher levels of 
expression before forming inclusion bodies. 
Expression of a target protein as a fusion protein with a highly soluble partner can greatly 
improve its solubility. Fusion proteins were originally constructed to facilitate protein 
purification and immobilisation, but soon it became apparent that certain fusion partners 
could improve the solubility of passenger proteins.  Different systems suitable for the 
construction of fusion proteins have been described, for example maltose-binding protein 
(MBP), thioredoxin and glutathione-S-transferase (GST). A likely reason for the 
improved folding (and/ or reduced degradation) of recombinant proteins is that the fusion 
partner rapidly reaches a native conformation and promotes the acquisition of correct 
structure in downstream folding units by favouring one-pathway isomerisation reactions. 
In a systematic comparison of the effectiveness of various fusion partners in increasing 
the solubility of six passenger polypeptides, it was found that MBP was far superior to 
either thioredoxin or glutathione-S-transferase as a solubilizing partner (Kapust and 
Waugh, 1999). 
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1.2.2. Translation issue problems 
The frequency of the codon-usage in eukaryotic cells and E.coli is different (Table 2). 
The problematic codons for bacterial expression of coding sequences derived from GC-
rich genomes are arg codons (AGG or AGA) and pro codon (CCC). If coding sequences 
from organisms with AT-rich genomes are used for expression in E.coli, tRNAs 
recognising AGA or AGG (arg), ATA (ile) and CTA (leu) can be limiting. This can cause 
low or lack of protein synthesis, early termination and misincorporation of amino acids in 
the expressed protein (Forman et al., 1998; Zahn, 1996). This so-called codon bias can be 
a significant obstacle for efficient expression of heterologous genes in E.coli. To solve 
this problem, new E.coli strains were developed, called E.coli BL21-Codon Plus strains. 
These strains derive from E.coli-BL21 strains that lack the Lon protease and the OmpT 
protease. E.coli BL21-Codon Plus-RIL cells (R= arg, I= ile, L= leu) contain extra copies 
of the argU, ileY, and leuW tRNA genes. These genes encode tRNAs that recognize the 
arg codons AGA and AGG, the ile codon ATA, and the leu codon CTA. E.coli BL21-
Table 2. Codon preferences of selected organisms 1 
Organism AGG arg AGA arg CGA arg CTA leu ATA ile CCC pro 
E.coli 1.4 2.1 3.1 3.2 4.1 4.3 
Homo sapiens 11 11.3 6.1 6.5 6.9 20.3 
Drosophila melanogaster 4.7 5.7 7.6 7.2 8.3 18.6 
Caenorhabditis elegans 3.8 15.6 11.5 7.9 9.8 4.3 
S. cerevisiae 9.3 21.3 3 13.4 17.8 6.8 
Plasmodium falciparum 4.1 20.2 0.5 15.2 33.2 8.5 
Clostridium pasteurianum 2.4 32.8 0.8 6 52.5 1 
Pyrococcus honkoshii 30.3 20.4 1 18 44.9 10.1 
Thermus aquaticus 13.7 1.4 1.4 3.2 2 43 
Arabidopsis thaliana 10.9 18.4 6 9.8 12.6 5.2 
1 Codon frequencies are expressed as codons used per 1,000 codons encountered. Codon frequencies of more than 15 
codons/ 1,000 codons are shown in bold to help identify a codon bias that may cause problems for high-level 
expression in E.coli. The arg codons AGG and AGA are recognized by the same tRNA (product of the argU gene) 
and should, therefore, be combined. However, regardless of the origin of the coding region of interest, each gene 
should be assessed individually. Even E.coli contain genes with poor codon usage for efficient translation (from 
Stratagene). 
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Codon Plus-RP cells (R= arg, P= pro) contain extra copies of the argU and proL genes, 
which encode tRNAs that recognize the arg codons AGA and AGG and the pro codon 
CCC. For that reason it can be reasonable to check the codon usage of the recombinant 
protein and to choose an appropriate E.coli BL21-Codon Plus strain. 
 
1.3. Bacterial expression of the three recombinant checkpoint proteins 
Rad9, Rad1 and Hus1 
It is known that the three checkpoint proteins Rad9, Rad1 and Hus1 are difficult to 
express in E.coli. Only little and incomplete data on bacterial expression of these proteins 
was found in the literature (Table 3). Eukaryotic expression systems can be used to 
produce soluble and functionally active protein for biochemical studies, but they are more 
complicated to handle than bacterial expression systems, more time consuming and yield 
relatively low protein amounts. Because bacterial systems are much easier to handle and 
provide higher amounts of protein, it was reasonable to try to establish optimal conditions 
to express each protein at reasonable levels, soluble and in a functionally active form. As 
mentioned above (see Introduction and Problem), different steps can be varied to improve 
bacterial expression and increase the amount of the soluble fraction. In this thesis, several 
E.coli strains were tested focussing on E.coli BL21-Codon Plus strains. Different tagged 
proteins were expressed and optimal conditions established in small-scale culture using a 
time-course analysis of the expressed protein. With optimised conditions, a large-scale 
protein expression was performed to purify high yields of soluble protein. By using these 
parameters, it was possible to express the two proteins Rad9 and Rad1 in good yields, 
and to some extend also Hus1. They could be purified to apparent homogeneity and were 
most likely properly folded since they could interact with each other in a so called Dot 
blot Far Western analysis. 
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Table 3. Bacterial expression of the three human checkpoint proteins Rad9, Rad1 and Hus1 
PROTEIN VECTOR BACTERIAL STRAIN 
EXPRESSION  
CONDITIONS 
INDUCTION RESULT REFERENCES 
Rad9 
GST-Rad9 
 
Rad9 
(His)6-Rad9 
MBP-Rad9 
 
Rad9 
GST-Rad9 
 
Rad9 
GST-Rad9 
GST-Rad9(224-391) 
 
Rad9 
GST-Rad9 
 
pGEX-KG 
 
 
pRSET 
pMalc-2 
 
 
pGEX1 
 
 
pGEX-5X-3 
pGEX-4T-1 
 
 
pGEX-4T-3 
 
not described 
 
 
Bacterial expression in 
E.coli 
 
 
Bacterial expression in 
E.coli 
 
Bacterial expression in 
E.coli 
 
 
Bacterial culture 
 
not described 
 
 
not described 
 
 
 
not described 
 
 
not described 
 
 
 
not described 
 
not described 
 
 
not described 
 
 
 
not described 
 
 
not described 
 
 
 
not described 
 
purified protein used to immunize 
rabbits 
 
both forms: 
overproduced at reasonable levels, 
soluble, nuclease activity 
 
purified protein used to generate 
polyclonal chicken antibodies 
 
purified protein used for 
immunization 
 
purified protein used for a peptide 
binding assay 
 
(Volkmer and Karnitz, 
1999) 
 
(Bessho and Sancar, 
2000) 
 
 
(St Onge et al., 1999) 
 
 
(Chen et al., 2001) 
 
 
(Schwartz et al., 2002) 
Rad1A 
(His)6-Rad1A 
Rad1 
(His)6-Rad1 
 
pRSET B 
 
pET 24a+ 
Bacterial expression in 
E.coli BL21 (DE3) 
 
not described 
 
A600 = 0.5 
 
not described 
0.5 mM IPTG 
20 hrs 
 
not described 
20% of Rad1A soluble 
 
purified protein used to immunize 
rabbits 
(Parker et al., 1998) 
 
(Volkmer and Karnitz, 
1999) 
Hus1 
GST-Hus1 
Hus1 
(His)6-Hus1 
 
pGEX-2TK 
 
pET 24a+ 
 
not described 
 
not described 
 
not described 
 
not described 
 
not described 
 
not described 
in vitro interaction between 
GSTHus1 and HDAC1 
purified protein used to immunize 
rabbits 
(Cai et al., 2000) 
 
(Volkmer and Karnitz, 
1999) 
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2. Materials and Methods 
2.1. Recombinant Rad9, Rad1 and Hus1 proteins 
The plasmid pGEX-4T-3-Rad1 was a gift from R. Freire (Teneriffa, Spain), pGEX-4T-3-
Rad9 and pREP4-Hus1 were a gift from K. Dahm (this institute). The Hus1 cDNA was 
amplified from the plasmid by PCR using the primers 5`-CAG GAT CCC ATA TGA 
AGT TTC GG and 5`-TAC GAT ATC CTA GGA CAG CGC AGG. The PCR product 
was digested with BamHI and EcoRV and inserted into pGEX-4T-3 (Amersham 
Pharmacia Biotech) to obtain the expression vector pGEX-4T-3-Hus1. The pGEX-4T-3-
Rad9 plasmid was digested with BamHI and AvaI and the fragment carrying the Rad9 
coding sequence inserted into pMalc-2E (New England Biolabs) to obtain pMalc-2E-
Rad9 plasmid allowing the expression of a maltose-binding protein (MBP)-Rad9 fusion 
protein. The insert sequence of all constructs was examined by partial sequencing. 
2.2. Bacterial strains 
E.coli-XL1-blue strain (Stratagene, La Jolla, CA 92037) was used as a host for plasmid 
amplification. E.coli BL21-Codon Plus-RIL and E.coli BL21-Codon Plus-RP strains 
(Stratagene, La Jolla, CA 92037) and E.coli-TB1 (New England Biolabs) and E.coli-TG1 
(Stratagene, La Jolla, CA 92037) strains were used for expression of GSTRad1, 
GSTRad9, MBPRad9 and GSTHus1, respectively. 
2.3. Buffer solutions 
The following buffers were used: lysis buffer A: 1x PBS (pH 7.3), 1%(v/v) Triton X-100, 
1mM EDTA, 1mM PMSF, 1mM DTT; lysis buffer B: 20mM Tris (pH 7.4), 200mM 
NaCl, 1mM PMSF, 1mM DTT; elution buffer A: 50mM Tris (pH 8), 150mM NaCl, 
1mM EDTA, 1mM PMSF, 1mM DTT, 10mM Glutathione; elution buffer B: 20mM Tris 
(pH 7.4), 200mM NaCl, 1mM EDTA, 1mM PMSF, 1mM DTT, 10mM maltose; buffer 
A: 20mM Tris (pH 8), 0.01%(v/v) NP-40, 10%(v/v) glycerol, 75mM NaCl, 1mM PMSF, 
1mM DTT; buffer B: 20mM Tris (pH 8), 0.01%(v/v) NP-40, 10%(v/v) glycerol, 1M 
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NaCl, 1mM PMSF, 1mM DTT; storage buffer: 50mM Tris (pH 7.4), 150mM NaCl, 1mM 
PMSF, 1mM EDTA, 1mM DTT, 10%(v/v) glycerol. SDS loading buffer: 50mM Tris (pH 
6.8), 100mM DTT, 2%(v/v) SDS, 0.1%(v/v) bromphenol blue, 10%(v/v) glycerol. 
2.4. Small-scale cultures of GSTRad1, GSTRad9, MBPRad9 and 
GSTHus1 
The respective plasmids were transformed into E.coli BL21-Codon Plus-RIL, E.coli 
BL21-Codon Plus-RP, E.coli-TB1 and E.coli-TG1 according to the manufacturer's 
instructions. A single colony was inoculated in 100ml of LB medium (containing 10g/l 
NaCl, 10g/l bacto-tryptone, 5g/l bacto yeast extract, brought to pH 7 with 5M NaOH and 
supplemented with 100µg/ml ampicillin). For E.coli BL21-Codon Plus strains, 50µg/ml 
chlormaphenicol was added additionally. The culture was incubated at 250 rpm at 30°C 
overnight. 5ml of the overnight culture was added to six Erlenmeyer flasks containing 
45ml of LB medium (supplemented with 100µg/ml ampicillin) and incubated to A600= 0.5 
or A600 = 1.0. For MBP-fusion proteins, LB medium was replaced by rich medium 
(containing 10g/l bacto-tryptone, 5g/l bacto yeast extract, 5g/l NaCl, 2g/l glucose, 
supplemented with 100µg/ml ampicillin). 1ml aliquots were collected from every flask (= 
uninduced cells), centrifuged at 6,500 rpm for 5 min. at 4°C and pellets were frozen at  
20°C. High level expression was induced by the addition of IPTG to a final 
concentration of 0.1mM, 0.5mM and 1.0mM. The six small-scale cultures were incubated 
at 250 rpm at 27°C. Every hour A600 was measured and two separate 1ml fractions were 
collected from each culture. The samples were centrifuged at 6,500 rpm for 5 min. at 4°C 
and the pellets were frozen at 20°C and used for solubility-checks and protein-
minipreparation experiments.  
2.5. Solubility-check of GSTRad1, GSTRad9, MBPRad9 and GSTHus1 
The pellets of the 1ml aliquots from small-scale cultures were resuspended in 200µl lysis 
buffer A for GST-tagged proteins and lysis buffer B for MBP-tagged proteins. The cells 
were lysed four times by freezing in liquid N2 and thawing at 37°C. Lysates were 
separated by centrifugation at 13,000 rpm for 10 min. at 4°C. Supernatant (soluble 
 17 
fraction) were transferred to new tubes and SDS loading buffer was added to 1x final 
concentration. The pellet  (insoluble fraction) was resuspended in 100µl lysis buffer A for 
GST-tagged proteins and lysis buffer B for MBP-tagged proteins and SDS loading buffer 
was added to 1x final concentration. After boiling for 5 min. at 100°C, the soluble and 
insoluble fractions were analysed separately by SDS-PAGE followed by Coomassie 
staining. 
The soluble fraction was analysed additionally by Western blot analysis. Therefore, the 
fractions were electrophoresed through a polyacrylamide gel. Proteins were electroblotted 
onto a nitrocellulose membrane and visualised by PonceauS staining to mark a low 
molecular weight marker LMW (Amersham Pharmacia Biotech). The membrane was 
destained using TBST (0.05%(v/v) Tween 20) and blocked for 1 hr in blocking solution 
(containing 5%(v/v) powder milk in TBST 0.05%(v/v) Tween20) at room temperature. 
α-GST or α-MBP polyclonal rabbit antibody were diluted 1:5,000 in blocking solution 
and the nitrocellulose membrane was incubated with diluted antibody for 1 hr at room 
temperature. Then the solution was removed and the membrane was washed two times 
for 20 min. and once for 10 min. with TBST (0.05%(v/v) Tween 20) and incubated again 
for 5 min. with blocking solution. HRP-conjugated goat anti-rabbit secondary antibody, 
diluted 1:10,000 in blocking solution, was added to the membrane and the membrane was 
incubated for 1 hr at room temperature, followed by 30 min. and 10 min. washing with 
TBST and 10 min. with TBS. Antibodies bound to protein antigens were detected by 
chemiluminescence using the ECL Detection System (Amersham Pharmacia Biotech) 
followed by exposure to an X-ray film (Eastman Kodak, Rochester, NY). 
 
2.6. Protein-minipreparation 
2.6.1. Protein-minipreparation of GST-tagged protein 
The pellets of the 1 ml aliquots collected from the small-scale cultures were resuspended 
in lysis buffer A, lysed by repeated freezing and thawing in liquid N2 and separated into 
soluble (supernatants) and insoluble protein fractions (pellets) by centrifugation as 
described for the solubility check (see 2.5.). Glutathione Sepharose 4B (Amersham 
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Pharmacia Biotech) was washed with 1xPBS and equilibrated with lysis buffer A 
resulting in a 50% slurry. 20µl slurry was then added to each supernatant and rotated for 
1 hr at 4°C. The suspension was centrifuged at 500g for 5 min. and the supernatant 
removed (unbound protein). Glutathione Sepharose 4B beads were washed 3 times with 
500µl lysis buffer A and once with 500µl lysis buffer A without Triton X-100. The pellet 
was finally resuspended in 50µl 1x SDS loading buffer and boiled for 5 min. at 100°C, 
followed by centrifugation at 6,500 rpm for 1 min.. 25µl of the samples containing 
protein eluted from the beads were resolved by SDS-PAGE and stained by Coomassie, 
25µl of samples were analysed by immunoblot analysis using the same procedure as 
described for the solubility check. 
2.6.2. Protein-minipreparation of MBP-tagged protein 
For the MBP-tagged protein, the same methods were used as described for GST-tagged 
protein, with the following alterations: the pellets of the 1 ml aliquots from the small-
scale cultures were resuspended in lysis buffer B. Amyloseresin (New England Biolabs) 
was washed and equilibrated with lysis buffer B resulting in a 50% slurry. 50µl slurry 
was added to each supernatant and rotated for 1 hr at 4°C. The Amylose-resin was 
washed only once with 1ml lysis buffer B. 
 
2.7. Purification of GSTRad1, MBPRad9 and GSTHus1 
2.7.1. MBPRad9 
2.7.1.1. Expression of a 1.6 l culture 
1µg of the plasmid pMalc-2E-Rad9 was transformed into E.coli BL21-Codon Plus-RP 
cells following the manufacturers instructions. 100µl of transformed cells were 
inoculated in 400 ml LB medium (supplemented with 50µg/ml ampicillin and 50µg/ml 
chloramphenicol). Then the culture was incubated at 250 rpm at 30°C overnight. 180 ml 
of the overnight culture was added to two Erlenmeyer flasks containing 700ml of rich 
medium, containing 10g/l bacto-tryptone, 5g/l bacto yeast extract, 5g/l NaCl, 2g/l 
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glucose, supplemented with 100µg/ml ampicillin, and incubated to A600=1.0. A 1ml 
aliquot was collected, centrifuged and the pellet was frozen at 20°C (= uninduced cells). 
IPTG was then added to a final concentration of 0.5mM and the culture incubated at 250 
rpm for 3 hrs at 27°C. A 1ml aliquot was collected, centrifuged and frozen at 20°C (= 
induced cells). The cells were harvested by centrifugation at 7,000 rpm for 30 min. at 
4°C, the pellet resuspended in 1xPBS and transferred to 50ml Falcon-Tubes. After 
centrifugation at 4,000 rpm for 30 min. at 4°, the pellet was frozen at 80°C until further 
use. 
 
2.7.1.2. Purification of MBPRad9 
2.7.1.2.1. Amylose-resin, batch-purification 
The bacterial pellet was resuspended in 40ml lysis buffer B and the bacteria were lysed 
two times by passage through a French press at 1200 psi. The lysate was separated into a 
soluble (supernatant) and an insoluble fraction (pellets) by centrifugation at 16,000 rpm 
for 30 min. at 4°C. The pellet was frozen at 20°C and a 1ml aliquot of the supernatant 
was collected, centrifuged and frozen at 20°C (load). 1ml amylose-resin was washed 
two times with 20ml lysis buffer B and equilibrated with 500µl lysis buffer, resulting in a 
50% slurry. The soluble protein fraction was rotated with the amylose-resin slurry for 2 
hrs at 4°C. After centrifugation at 500g for 5 min., the supernatant was removed 
(unbound protein) and the resin washed 3 times with 10ml, 5ml and 5ml lysis buffer B. 
The pooled wash fractions were saved. Bound protein was eluted 6 times with 500µl 
elution buffer B by rotating each for 10 min. at 4°C, centrifugation at 500g for 5 min. and 
collecting the supernatant. Load, unbound protein, wash and 10µl of each collected 
fraction of eluted protein were resolved by SDS-PAGE and analysed by Coomassie 
staining. Those fractions containing MBPRad9 were pooled and dialysed overnight at 
4°C against 1 l of buffer A. 
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2.7.1.2.2. Anion exchanger HiTrap Q 
A prepacked 1ml HiTrap Q anion exchange column (Amersham Pharmacia Biotech) was 
equilibrated with 10ml buffer A at a flow rate of 1ml/min. The pooled and dialysed 
fractions were loaded onto the column at a flow rate of 0.25ml/min using a FPLC-system. 
The flow through was saved. The column was washed with 2.5ml buffer A at a flow rate 
of 0.5ml/min. Bound protein was eluted with buffer B at a flow rate of 0.5ml/min with a 
continuous 10ml salt gradient at an increase in ionic strength from 75mM to 1M NaCl. 
Fractions of 0.25ml were collected and the load, flow through and 10µl of each fraction 
resolved by SDS-PAGE and analysed by Coomassie staining. Those fractions containing 
MBPRad9 were pooled to a main pool and two side pools and dialysed overnight at 4°C 
against 1 l storage buffer. The pools were aliquoted into 100µl and frozen at 80°C until 
further use. The protein content of each pool was quantified by Bradford assay and 
analysed by SDS-PAGE and Coomassie staining. 
 
2.7.2. GSTRad1 
2.7.2.1. Expression of a 2 l culture 
1µg of the plasmid pGEX-4T-3-Rad1 was transformed into E.coli BL21-Codon Plus-RIL 
cells following the manufacturers instructions. A single colony was inoculated in 300 ml 
LB medium (supplemented with 100µg/ml ampicillin and 50µg/ml chloramphenicol). 
The culture was incubated at 250 rpm at 30°C overnight. 70 ml of the overnight culture 
was added to three Erlenmeyer flasks containing 630ml of LB medium (supplemented 
with 100µg/ml ampicillin), and incubated to A600=1.0. A 1ml aliquot was collected, 
centrifuged and the pellet was frozen at 20°C (= uninduced cells). IPTG was added to a 
final concentration of 1mM and the culture incubated at 250 rpm for 3 hrs at 25°C. A 1ml 
aliquot was collected, centrifuged and frozen at 20°C (= induced cells). The cells were 
harvested by centrifugation at 7,000 rpm for 30 min. at 4°C, the pellet was resuspended in 
1xPBS and transferred to 50ml Falcon-Tubes. After centrifugation at 4,000 rpm for 30 
min. at 4°C, the pellet was frozen at 80°C until further use. 
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2.7.2.2. Purification of GSTRad1 
2.7.2.2.1. GSTrap 
The bacterial pellet was resuspended in 40ml lysis buffer A and the bacteria were lysed 
two times by passage through a French press at 1200 psi. The lysate was separated into a 
soluble (supernatant) and an insoluble fraction (pellet) by centrifugation at 16,000 rpm 
for 30 min. at 4°C. The pellet was frozen at 20°C and a 1ml aliquot of the supernatant 
collected, centrifuged and frozen at 20°C (load). A prepacked 1ml GSTrap column 
(Amersham Pharmacia Biotech) was equilibrated with 10ml lysis buffer A. The 
supernatant was passed through a 45µm filter and applied to the column at a flow rate of 
0.5 ml/min by using a FPLC-system. The flow through was saved and the column washed 
with 15ml lysis buffer A followed by 15ml lysis buffer A without Triton X-100 at a flow 
rate of 0.5ml/min..The pooled wash fractions were saved. The bound protein was eluted 
with 10ml elution buffer A at a flow rate of 0.5ml/min and fractions of 0.25 ml were 
collected. Load, flow through, wash and 10µl of each fraction were resolved by SDS-
PAGE and analysed by Coomassie staining. Those fractions containing GSTRad1 were 
pooled and dialysed overnight at 4°C against 1 l of buffer A. 
2.7.2.2.2. Anion exchanger HiTrap Q 
A prepacked 1ml HiTrap Q anion exchange column (Amersham Pharmacia Biotech) was 
equilibrated with 10ml of buffer A at 1ml/min.. The pooled and dialysed fractions were 
loaded onto the column at a flow rate of 0.25ml/min by using a FPLC-system. The flow 
through was saved and the column was washed with 2.5ml buffer A at a flow rate of 
0.5ml/min. Bound protein was eluted with buffer B at a flow rate of 0.5ml/min with a 
continuous 10ml salt gradient at an increase in ionic strength from 75mM to 1M NaCl. 
Fractions of 0.25ml were collected and the load, flow through and 10µl of each fraction 
resolved by SDS-PAGE and analysed by Coomassie staining. Those fractions containing 
GSTRad1 were pooled to a main pool and two side pools and dialysed overnight at 4°C 
against 1 l storage buffer. The pools were aliquoted into 100µl and frozen at 80°C until 
further use. The protein content of each pool was quantified by Bradford assay and 
analysed by SDS-PAGE and subsequent Coomassie staining or immunoblot analysis. 
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2.7.3. GSTHus1 
2.7.3.1. Expression of a 4 l culture  
1µg of the plasmid pGEX-4T-3-Hus1 was transformed into E.coli -TB1 cells following 
the manufacturers instructions. 100µl transformed cells were inoculated in 500 ml LB 
medium (supplemented with 50µg/ml ampicillin). The culture was incubated at 250 rpm 
at 30°C overnight. 100 ml of the overnight culture was added to four Erlenmeyer flasks 
containing 900ml of LB medium (supplemented with 50µg/ml ampicillin), and incubated 
to A600= 0.4. A 1ml aliquot was collected, centrifuged and the pellet frozen at 20°C (= 
uninduced cells). IPTG was added to a final concentration of 0.5mM and the culture 
incubated at 250 rpm for 5 hrs at 27°C. A 1ml aliquot was collected, centrifuged and 
frozen at 20°C (= induced cells). The cells were harvested by centrifugation at 7,000 
rpm for 30 min. at 4°C, the pellet resuspended in 1xPBS and transferred to 50ml Falcon-
Tubes. After centrifugation at 4,000 rpm for 30 min. at 4°C, the pellet was frozen at  
-80°C until further use. 
2.7.3.2. Purification of GSTHus1 
For purification of GSTHus1, the same columns, methods and buffers were used as 
described for GSTRad1. 
 
2.8. Dot blot Far Western analysis 
Purified MBPRad9 (3µg, 5µg and 7µg) was dotted onto nitrocellulose (0.22µm 
Osmonics, Westborough) and air dried for 30 min. at 4°C. The nitrocellulose was then 
rehydrated 5 min. in aqua bidest and blocked in TBS, 5%(v/v) powder milk and 
0.05%(v/v) Tween 20 for 1 hr at 4°C, followed by two short washes of 1 min. with TBS 
0.05%(v/v) Tween 20, 0.1%(v/v) BSA. The membrane was then incubated with 
GSTRad1 or GSTHus1 (1µg/ml) in TBS supplemented with 0.05%(v/v) Tween 20, 
0.1%(v/v) BSA, 1mM DTT and 1mM PMSF for 3 hrs at 4°C. The membrane was washed 
four times for 10 min. at 4°C in TBS containing 0.05%(v/v) Tween 20. The second wash 
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contained 0.0001%(v/v) glutaraldehyde. Then the nitrocellulose was again blocked in the 
above mentioned buffer for 1 hr at room temperature. An immunoblot analysis was then 
performed to detect the presence of GSTRad1 or GSTHus1 using α-GST polyclonal 
rabbit antibody (Santa Cruz Biotechnology, California) previously diluted 1:5,000 in 
blocking solution. The nitrocellulose membrane was incubated with diluted antibody for 
1 hr at room temperature. Then the membrane was washed two times for 20 min. and 10 
min. each with TBST (0.05%(v/v) Tween 20) and blocked again for 5 min.. Finally HRP-
conjugated anti-rabbit secondary antibody, diluted 1:10,000 in blocking solution, was 
added, the membrane incubated for 1 hr at room temperature, followed by 30 min. and 10 
min. washings with TBST (0.05%(v/v) Tween 20) and 10 min. with TBS. Antibodies 
bound to the two proteins were detected by chemiluminescence by using the ECL 
Detection System (Amersham Pharmacia Biotech) followed by exposure to an X-ray film 
(Eastman Kodak, Rochester, NY). 
 
3. Results 
3.1. Rad1 
3.1.1. Fusion protein and expression conditions 
There is only little and incomplete data published in the literature on bacterial expression 
of Rad1 (Table 3). One paper describes bacterial expression of (His)6-tagged Rad1 using 
a pRSET B vector (Parker et al., 1998). Two truncated forms of Rad1, called Rad1A and 
Rad1B were expressed in E.coli BL21 (DE3). Approximately 20% of expressed Rad1A 
was found in the soluble fraction, whereas for Rad1B, the expressed recombinant protein 
was almost completely insoluble. A second paper described bacterial expression of Rad1 
using a pET 24a+ vector (Volkmer and Karnitz, 1999). But they published no data about 
bacterial strain, expression conditions and solubility of the purified protein, which was 
used to immunize rabbits. Because of this incomplete information in the literature, it was 
reasonable to express Rad1 as a different fusion-protein, using a pGEX-4T-3 plasmid to 
get a GST-tagged protein, GSTRad1. 
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3.1.2. Bacterial strain 
GSTRad1 is a 58.5 kDa protein. First, the codon sequence of this protein was checked, 
focussing on the critical codons arg (AGG, AGA, CGA), leu (CTA), ile (ATA) and pro 
(CCC) (Table 4). 
 
Table 4. Codon frequencies of critical codons in GSTRad1 and E.coli 1 
Amino-acid Codon GSTRad1 E.coli 
arg AGG 15.3 1.4 
 AGA 12.8 2.1 
 CGA 12.8 3.1 
leu CTA 10.3 3.2 
ile ATA 25.6 4.1 
pro CCC 4.3 4.3 
 
1 Codon frequencies are expressed as codons used per 1,000 codons encountered. The two codon 
frequencies of GSTRad1 that differ most from E.coli are shown in bold to help identify a codon bias that 
may cause problems for high-level expression in E.coli. 
 
It was found that the most critical codons are AGG (arg), followed by ATA (ile) and 
AGA (arg), less critical are CGA(arg), CTA (leu) and CCC (pro). Therefore, it was 
reasonable to express Rad1 in E.coli BL21-Codon Plus-RIL cells containing extra copies 
of the argU, ileY and leuW tRNA genes (see Introduction and Problem). 
 
3.1.3. Small scale cultures and solubility check of GSTRad1 
3.1.3.1. GSTRad1 expressed in E.coli BL21-Codon Plus-RIL 
To establish optimal growth and expression conditions for GSTRad1 in E.coli BL21-
Codon Plus-RIL cells, small scale cultures were used and six different expression 
conditions were tested (Table 5). 
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Table 5. Expression conditions and cell growth after induction of GSTRad1 in  
E.coli -Codon Plus-RIL cells 
Expression conditions 1 h 2 h 3 h 4 h 5 h 6 h 
A600=1 25°C 1mM IPTG LB A600 1.23 A600 1.42 A600 1.67 A600 1.82 A600 2.05 A600 2.05 
 25°C 0.5mM IPTG LB A600 1.26 A600 1.42 A600 1.74 A600 1.87 A600 2.06 A600 2.38 
 25°C 0.1mM IPTG LB A600 1.29 A600 1.44 A600 1.77 A600 1.94 A600 2.19 A600 2.37 
A600=0.5 25°C 1mM IPTG LB A600 0.75 A600 0.88 A600 1.17 A600 1.32 A600 1.43 A600 1.70 
 25°C 0.5mM IPTG LB A600 0.78 A600 0.92 A600 1.16 A600 1.34 A600 1.46 A600 1.64 
 25°C 0.1mM IPTG LB A600 0.77 A600 0.95 A600 1.22 A600 1.37 A600 1.60 A600 1.77 
 
Two separate 1ml fractions were collected from each culture before (uninduced cells) and 
every hour after induction (induced cells) to get a time course analysis of the expression 
level and to establish the optimal induction period. A600 was measured every hour to 
check the cell growth after induction and thereby judging the toxicity of the expressed 
GSTRad1 protein on the bacterial cells (Table 5). The cells of the collected fractions were 
lysed and lysates were separated by centrifugation. The soluble (supernatants) and 
insoluble fractions (pellets) were analysed separately by SDS-PAGE followed by 
Coomassie staining (Figure 3A). The soluble fractions were analysed additionally by 
immunoblot analysis (Figure 3B). According to this small-scale culture and solubility 
check, GSTRad1 is expressed, as expected, prevailing insoluble and can be found in 
increasing amount in the pellet over the expression period (Figure 3A, not all conditions 
shown). On the other hand a reasonable amount of soluble protein without distinct 
degradation was present in each condition tested (Figure 3B, not all conditions shown). 
The amount of soluble expressed GSTRad1 detected in the supernatant by immunoblot 
analysis (Figure 3B) stayed almost constant over the expression period and did not differ 
significantly between the different expression conditions tested. In addition, according to 
the measured optical density (A600) (Table 5), it can be mentioned that GSTRad1 showed 
no obvious toxicity to the bacterial cells. 
To test the correct folding of expressed GSTRad1 protein by its binding to Glutathione 
Sepharose 4B, each collected fraction was additionally analysed by protein-
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minipreparation. Therefore, the soluble fraction of each expression condition was 
incubated with Glutathione Sepharose 4B and the bound protein fraction was analysed by 
SDS-PAGE followed by subsequent Coomassie staining (Figure 3C, not all conditions 
shown) or immunoblot analysis (Figure 3D, not all conditions shown). Soluble and bound 
GSTRad1 recombinant protein bacterially expressed in E.coli BL21-Codon Plus-RIL 
could be found in each expression condition tested, but the amount of bound protein was 
higher at A600=1 than at A600=0.5 (Figure 3C). It appeared that protein-minipreparation by 
Glutathione Sepharose 4B can lead to some protein degradation that could be detected by 
immunoblot analysis and that the amount of degraded protein was increasing over the 
expression period (Figure 3D, not all conditions shown).  
 
3.1.4. Optimised expression conditions for Rad1 
Rad1 seemed to be expressed at reasonable levels as a GST-tagged fusion protein in 
E.coli BL21-Codon Plus-RIL, and although the amount of insoluble expressed GSTRad1 
recombinant protein was higher than the soluble protein fraction, soluble protein could be 
found in every condition tested showing no distinct degradation. The amount of soluble 
GSTRad1 protein that bound to Glutathione Sepharose 4B was significantly higher at 
A600=1. Degradation was present at every expression condition tested, but it appeared to 
increase over the expression period. Therefore a high cell density (A600) at the time of 
induction and a high concentration of IPTG was chosen to get a high level of expression 
during the induction period, but thereby keeping the expression period short to limit 
protein degradation. The expression condition chosen was A600=1, 1mM IPTG, at 25°C 
for 3hrs. 
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Figure 3A. Expression of GSTRad1 in E.coli BL21-Codon Plus-RIL, pellet, Coomassie stained gel. A 
Coomassie blue-stained 12% SDS-polyacrylamide gel of the insoluble fractions (pellets) of GSTRad1 
expressed in E.coli BL21-Codon Plus-RIL strain is shown. 10µl of each collected 1ml fraction was loaded. 
Lanes: 1, low molecular weight markers; 2, uninduced cells, 3-8, culture induced at A600=1 with 1mM 
IPTG, 1-6 hrs of induction; 9-14, culture induced at A600=1 with 0.5mM IPTG, 1-6 hrs of induction. The 
position of the GSTRad1 band is indicated by an arrow on the right. 
 
Figure 3B. Expression of GSTRad1 in E.coli BL21-Codon Plus-RIL, supernatant, immunoblot 
analysis. 25µl of the soluble fraction of each collected 1ml fraction was analysed by 12% SDS-
polyacrylamide gel followed by Western blot analysis using a α-GST polyclonal rabbit antibody diluted 1: 
5,000. Left side: Lanes: 1, low molecular weight markers; 2, positive control GSTRad17; 3, negative 
control Aldolase; 4, uninduced cells; 5-10, culture induced at A600=1 with 1mM IPTG, 1-6 hrs of 
induction; 11-13, culture induced at A600=1 with 0.5mM IPTG, 1-3 hrs of induction. Right side: Lanes: 1, 
low molecular weight markers; 2, uninduced cells; 3-5, culture induced at A600=1 with 0.5mM IPTG, 4-6 
hrs of induction. The position of the GSTRad1 band is indicated by an arrow on the right. 
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Figure 3C. Expression of GSTRad1 in E.coli BL21-Codon Plus-RIL, protein-minipreparation of the 
soluble fraction, Coomassie stained gel. The soluble fraction of each collected 1ml aliquot was incubated 
with washed and equilibrated Glutathione Sepharose 4B 50% slurry. Unbound protein was removed, 
Glutathione Sepharose 4B beads were washed and protein was eluted as described in Materials and 
Methods. 20µl of the samples containing eluted protein were resolved by SDS-PAGE and stained by 
Coomassie. Left side: Lanes: 1, low molecular weight markers; 2, GSTRad17; 3, Aldolase; 4-9, culture 
induced at A600=1 with 1mM IPTG, 1-6 hrs of induction; 10-15, culture induced at A600=1 with 0.5mM 
IPTG, 1-6 hrs of induction; Right side: Lanes: 1, low molecular weight markers; 2, uninduced cells; 3-8, 
culture induced at A600=0.5 with 1mM IPTG, 1-6 hrs of induction; 9-14, culture induced at A600=0.5 with 
0.5mM IPTG, 1-6 hrs of induction. The position of the GSTRad1 band is indicated on the right. 
 
Figure 3D. Expression of GSTRad1 in E.coli BL21-Codon Plus-RIL, protein-minipreparation of the 
soluble fraction, immunoblot analysis. The fractions were treated as described for Figure 3C. 20µl of the 
samples containing eluted protein were resolved by SDS-PAGE and analysed by Western blot analysis 
using a α-GST polyclonal rabbit antibody. Lanes: 1, low molecular weight markers; 2, positive control 
GSTRad17; 3, negative control Aldolase; 4-9, culture induced at A600=1 with 1mM IPTG, 1-6 hrs of 
induction; 10-15, culture induced at A600=1 with 0.5mM IPTG, 1-6 hrs of induction. The position of the 
GSTRad1 band is indicated by an arrow on the right. Degradation is indicated by  * . 
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3.1.5. Big culture and purification of GSTRad1 in E.coli BL21-Codon Plus-RIL 
3.1.5.1. Purification of GSTRad1 by a GSTrap column 
pGEX-4T-3-Rad1 plasmid was transformed into E.coli BL21-Codon Plus-RIL cells as 
described above. A single transformed colony was inoculated in LB medium, which was 
then expanded to a 2 l culture. Expression was started at A600=1 by adding IPTG to a final 
concentration of 1mM and culture was incubated at 25°C for 3 hrs at 250 rpm. The cells 
were harvested by centrifugation and resuspended in lysis buffer as described above. 
Bacteria were lysed by passage through a French press and separated into a soluble and 
insoluble fraction by centrifugation. The filtered soluble fraction was applied to a 
prepacked and equilibrated GSTrap column using a FPLC-system. The column was 
washed, bound protein was eluted with elution buffer and fractions were collected. Load, 
flow through, wash and the collected fractions were analysed by SDS-PAGE and 
Coomassie staining (Figure 4A). Soluble purified GSTRad1 protein was present in 
fractions 5-28. After this first purification step, GSTRad1 was not that concentrated and 
some degradation and contamination were present. Therefore a second purification step 
was necessary and for this the fractions containing GSTRad1 (fractions 5-28) were 
pooled.  
3.1.5.2. Purification of GSTRad1 by an anion exchanger HiTrap Q 
Based on the codon sequence of GSTRad1, its pI (pIGSTRad1 = 5.03) was calculated and a 
anion exchanger (HiTrap Q) was chosen as next purification step. Enrichment of the 
target protein GSTRad1 is thereby achieved by choosing a start buffer (buffer A) with a 
pH at least 1 unit above the pI of substance to be bound (pIGSTRad1= 5.03). Exposed to this 
buffer A, GSTRad1 carries a negative charge and binds to an anion exchanger (HiTrap 
Q). For buffer A pH 8 was chosen and the pooled fractions were dialysed against this 
buffer A and loaded onto the column using a FPLC-system. After several washing steps, 
bound protein was eluted with a continuous salt gradient at an increase in ionic strength. 
Fractions were collected and load, flow through, wash and the collected fractions were 
analysed by SDS-PAGE and Coomassie staining (Figure 4B). GSTRad1 was mostly 
present in fractions 13-28, especially in fractions 17-22. Some GSTRad1 recombinant 
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protein did not bind properly to the column and was therefore present in the flow through. 
So it was concluded that pH 8 of buffer A was probably not high enough for a sufficient 
binding of GSTRad1 to the anion exchanger. On the other hand, a higher chosen pH for 
buffer A could have led to additional protein degradation, what fortunately did not 
happen during this second purification step. Nevertheless, some degraded protein was 
still present and eluted exactly at the same fractions as non-degraded GSTRad1 protein. 
According to this observation, it was concluded that this degradation would be very hard 
to separate by further purification steps and probably additional degradation would 
appear, as observed during protein-minipreparation of GSTRad1 (see above). Therefore, 
no further purification step was done for recombinant GSTRad1 protein. The fractions 
containing GSTRad1 were pooled to a main pool (Pool 1, fractions 17-22) and two side 
pools (Pool 2, fractions 13-16; Pool 3, fractions 23-28). The protein content of each pool 
was quantified by Bradford assay (see Discussion, Table 10) and analysed by SDS-PAGE 
followed by subsequent Coomassie staining (Figure 4C) or immunoblot analysis (data not 
shown).The pools were finally dialysed against a storage buffer and frozen at 80°C until 
further use (see Activity test, Figure 12). 
Figure 4A. GSTRad1 purification , 2 l culture, GSTrap column, Coomassie stained gel. The bacterial 
pellet of a 2 l culture of E.coli BL21-Codon Plus-RIL expressing GSTRad1 was resuspended, lysed and the 
soluble fraction filtered as described in Materials and Methods. The filtered supernatant was applied to an 
equilibrated GSTrap column using a FPLC-system, followed by several washing steps. Bound GSTRad1 
protein was eluted from the column as described above. 0.25ml fractions were collected and 1µl load, 1µl 
flow through , 1µl wash and 10µl of each collected fraction were resolved by 12% SDS-PAGE and 
analysed by Coomassie staining. Left side: Lanes: 1, low molecular weight markers; 2, load; 3, flow 
through; 4, wash; 5-15, 10µl of each fraction 4-14 containing GSTRad1 protein eluted from the GSTrap 
column. Right side: Lanes: 1, low molecular weight markers; 2-15, 10µl of each fraction 15-28 containing 
GSTRad1 protein eluted from the GSTrap column. The position of the GSTRad1 band is indicated by an 
arrow on the right. 
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Figure 4B. GSTRad1 purification, collected fractions after anion exchange column, Coomassie 
stained gel. Pooled and dialysed fractions from 4A. were loaded onto a prepacked and equilibrated HiTrap 
Q anion exchange column as described in Materials and Methods. The column was washed, the protein 
eluted and 0.25ml fractions were collected. Aliquots of the load, flow through and 10µl of each collected 
0.25ml fraction were analysed by 12% SDS-PAGE followed by Coomassie staining. Left side: Lanes: 1, 
low molecular weight markers; 2, 10µl load; 3, 10µl wash; 4, 10µl flow through; 5-15, 10µl of each 
fraction 9-19 containing GSTRad1 protein eluted from the anion exchange column. Right side: Lanes: 1, 
low molecular weight markers; 2-15, 10µl of each fraction 20-33 containing GSTRad1 protein eluted from 
the anion exchange column. The position of the GSTRad1 band is indicated by an arrow on the right. 
 
 
 
Figure 4C. GSTRad1 purification, Pool 1, Pool 2 and Pool 3 
after two-step purification, Coomassie stained gel. After the anion 
exchange column HiTrap Q, fractions 17-22, containing the main 
part of GSTRad1 were pooled to a main pool, Pool 1, and analysed 
by SDS-PAGE followed by Coomassie staining. Two side pools, 
Pool 2 and Pool 3, containing the fractions 13-16 and 23-28, 
respectively, were additionally analysed. Lanes: 1, 10µl of Pool 1; 2, 
10µl of Pool 2; 3, 10µl of Pool 3; 4, low molecular weight markers. 
The position of the GSTRad1 band is indicated by an arrow on the 
left. 
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3.2. Rad9 
3.2.1. Fusion protein and expression conditions 
Although a considerable amount of literature is published on structure, function and 
interaction of Rad9, only little data is available on its bacterial expression. Most of the 
authors prefer other expression systems, especially yeast cells, probably knowing about 
the problems of bacterial expression of this human checkpoint protein. Data published on 
bacterial expression of recombinant Rad9 protein is shown in Table 3. Four research 
groups tried to express recombinant Rad9 in a pGEX-vector to get a GST-tagged fusion 
protein, GSTRad9 (Schwartz et al., 2002; Chen et al., 2001; St Onge et al., 1999; 
Volkmer and Karnitz, 1999). All the authors except Schwartz et al. used purified 
GSTRad9 to immunize rabbits and to get anti-GSTRad9-antibody. Schwartz et al. used 
purified GSTRad9 recombinant protein for a functional assay, a peptide binding assay. 
Nevertheless, there is no data about the solubility of expressed GSTRad9 and its 
expression level. Secondly, a paper was found which describes bacterial expression of 
recombinant Rad9 (Bessho and Sancar, 2000). These authors used a pRSET and pMalc-2 
expression vector to get (His)6-Rad9 and MBPRad9, respectively, and expressed it in 
E.coli. They mentioned that both forms were overproduced at reasonable levels and 
were soluble. Nevertheless they described that the (His)6-Rad9 form contained some 
contaminants even after four-column purification procedure so that they conducted most 
experiments with MBPRad9 recombinant protein. Even in this paper nothing is 
mentioned about exact E.coli strain or the expression conditions used. According to the 
published data (Schwartz et al., 2002; Chen et al., 2001; St Onge et al., 1999; Volkmer 
and Karnitz, 1999) the bacterial expression of GSTRad9 was tested using a pGEX-4T-3 
expression vector. Additionally, a pMalc-2E expression vector was used to get a MBP-
fusion protein, MBPRad9 (Bessho and Sancar, 2000). 
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3.2.2. Bacterial strain 
Based on the encouraging results with bacterial expression of GSTRad1, an E.coli BL21- 
Codon Plus strain was first tested to circumvent the problem of codon bias (see 
Introduction and Problem). Therefore the codon sequence of GSTRad9 and MBPRad9 
was checked and codon frequencies were compared with E.coli (Table 6). GSTRad9 
contains 616 codons and has a molecular weight (MW) of 68.7 kDa whereas MBPRad9 
contains 783 codons and its moelcular weight is 85.4 kDa. 
 
Table 6. Codon frequencies of critical codons in GSTRad9, MBPRad9 and E.coli 1 
Amino-acid Codon GSTRad9 MBPRad9 E.coli 
arg AGG 3.25 3.83 1.4 
 AGA 3.25 0 2.1 
 CGA 3.25 0 3.1 
leu CTA 3.25 0 3.2 
ile ATA 8.12 1.28 4.1 
pro CCC 29.22 20.43 4.3 
 
1 Codon frequencies are expressed as codons used per 1,000 codons encountered. The codon frequency of 
GSTRad9 or MBPRad9, respectively, that differs most from E.coli is shown in bold to help identify a 
codon bias that may cause problems for high-level expression in E.coli. 
 
According to this comparison it became clear that the codon frequence of the pro codon 
CCC was much higher in either GSTRad9 or MBPRad9 compared to E.coli. It was 
therefore reasonable to select an E.coli BL21-Codon Plus-RP strain, which includes 
expression plasmids that contains the tRNA genes proL and argU. The corresponing 
tRNAs recognize the pro codon CCC and the arg codons AGA/AGG, respectively. So the 
pro codon seems to be the most critical one in bacterial expression of Rad9 fusion protein 
(Table 6). To be able to compare the effect of the bacterial expression of recombinant 
Rad9 protein in this special E.coli BL21-Codon Plus-RP strain, a conventional E.coli 
strain, E.coli –TB1, was additionally tested in expressing recombinant MBPRad9 protein. 
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3.2.3. Small scale cultures and solubility check of GSTRad9 and MBPRad9 
As described for Rad1 (see above), optimal growth and expression conditions for 
GSTRad9 and MBPRad9 were established by small-scale culture and solubility check. 
The expression conditions tested for Rad9 are shown in Table 7.  
A600 was measured every hour during the induction period (data not shown) and fractions 
were collected as described for GSTRad1 (see above). For MBP-fusion proteins, LB 
medium was replaced by rich medium, following manufacturers instructions. 
 
3.2.3.1. GSTRad9 expressed in E.coli BL21-Codon Plus-RP 
Collected fractions were treated as described for GSTRad1. The insoluble fractions were 
visualised by Coomassie staining (Figure 5A), whereas the soluble fractions were 
analysed by SDS-PAGE followed by subsequent Coomassie staining (data not shown) or 
immunoblot analysis (Figure 7A), respectively. Additionally, the soluble fractions were 
Table 7. Expression conditions tested for Rad9 
GSTRad9 in E.coli-Codon Plus-RP Expression conditions 
A600=1 1mM IPTG 
 0.5mM IPTG 
 0.1mM IPTG 
A600=0.5 1mM IPTG 
 0.5mM IPTG 
 0.1mM IPTG 
LB, 27°C 1h, 2h, 3h, 4h, 5h, 6h 
MBPRad9 in E.coli-Codon Plus-RP Expression conditions 
A600=1 0.5mM IPTG 
 0.1mM IPTG 
A600=0.5 0.5mM IPTG 
 0.1mM IPTG 
Rich media, 27°C 2h, 3h, 5h 
MBPRad9 in E.coli-TB1 Expression conditions 
A600=1 0.5mM IPTG 
 0.1mM IPTG 
A600=0.5 0.5mM IPTG 
 0.1mM IPTG 
Rich media, 27°C 2h, 3h, 5h 
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tested on their binding to Glutathione Sepharose 4B by a protein-minipreparation as 
described for GSTRad1 and the soluble bound GSTRad9 protein was analysed by SDS-
PAGE followed by Coomassie staining (Figure 6A) or immunoblot analysis (data not 
shown), respectively. 
According to the small scale cultures and solubility check of GSTRad9 expressed in 
E.coli BL21-Codon Plus-RP, it can be summerized that GSTRad9 is indeed expressed at 
a reasonable level, but it is mostly present as an insoluble form and appears in increasing 
amount in the pellet during the induction period (Figure 5A, not all conditions shown). 
The soluble fractions analysed showed distinct degradation detected by immunoblot 
analysis (Figure 7A). Additionally, bacterial expression of GSTRad9 in E.coli BL21-
Codon Plus-RP was generally leaky. After protein-minipreparation no bound and soluble 
protein could be detected either by Coomassie stained gel (Figure 6A, not all conditions 
shown) nor by immunoblot analysis (data not shown). 
3.2.3.2. MBPRad9 expressed in E.coli BL21-Codon Plus-RP 
Small scale cultures were used as described for GST-fusion proteins and different 
expression conditions were tested as written in Table 7. The insoluble fractions (pellets) 
were analysed by SDS-PAGE and Coomassie staining (Figure 5B), whereas the soluble 
fractions (supernatants) were directly used for protein-minipreparation. Thereby, washed 
and equilibrated Amylose-resin was incubated with the soluble fractions of each 
expression condition as described above (see Materials and Methods). The bound and 
soluble protein was then analysed by SDS-PAGE and Coomassie staining (Figure 6B) or 
immunoblot analysis (Figure 7B), respectively. Comparing these results with GSTRad9 
expression in E.coli BL21-Codon Plus-RP, it is obvious that the expression level of 
MBPRad9 is distinctly higher, although the same E.coli strain was used. A bigger amount 
of insoluble protein could be found in the pellet (Figure 5B) and, opposite to GSTRad9, a 
reasonable amount of soluble protein bound to Amylose-resin in each expression 
condition tested (Figures 6B, 7B). Thereby the highest amount of soluble bound protein 
was expressed at A600=0.5, 0.1mM IPTG, 5-7 hrs induction (Figures 6B, 7B), but there 
was a lot of degraded protein present (Figure 7B). A600=1, 0.5mM IPTG, 3-4 hrs 
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induction was chosen as the best expression condition, showing little less expressed 
MBPRad9 protein but also less degradation. 
3.2.3.3. MBPRad9 expressed in E.coli-TB1 
Small scale cultures, solubility check and protein-minipreparation of MBPRad9 in E.coli-
TB1 was done using the same methods as described for MBPRad9 in E.coli BL21-Codon 
Plus-RP. The insoluble fractions (pellets) were analysed by SDS-PAGE followed by 
Coomassie staining (Figure 5C), whereas the soluble fractions (supernatants) were used 
for protein-minipreparation as described above and soluble bound protein was analysed 
as well by SDS-PAGE and Coomassie staining (Figure 6C) or immunoblot analysis 
(Figure 7C), respectively. It was interesting that both E.coli-TB1 as well as E.coli BL21-
Codon Plus-RP expressed MBPRad9 at the same high level (Figures 5B, 5C). On the 
other hand, the soluble and bound MBPRad9 protein fraction was clearly lower in E.coli-
TB1 (Figures 6C, 7C). Nevertheless, bound and soluble expressed MBPRad9 protein 
could be found in every expression condition tested. The best condition was A600=0.5, 
0.5mM IPTG, 5 hrs induction, although a lot of degraded protein was present. 
3.2.4. Optimised expression conditions for Rad9 
As a conclusion of all these data from small-scale culture, solubility check and protein-
minipreparation, it was decided to express Rad9 as a MBP-fusion protein, because the 
expression level was clearly improved compared to GSTRad9 protein expression, and 
soluble and bound recombinant MBPRad9 protein could be found at reasonable levels. 
Comparing the two bacterial strains E.coli BL21-Codon Plus-RP and E.coli-TB1, the first 
one was clearly superior in expressing soluble recombinant MBPRad9 protein. Based on 
the observation of increasing degradation at A600=0.5 during induction period, MBPRad9 
was expressed in E.coli BL21-Codon Plus-RP using following expression conditions: 
Induction at A600=1 with 0.5mM IPTG and an induction period of 3 hrs at 27°C in rich 
media. 
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Figure 5A. GSTRad9 expression in E.coli BL21-Codon Plus-RP, pellets, Coomassie stained gel. A 
Coomassie blue-stained 12% SDS-polyacrylamide gel of the insoluble fractions (pellets) of GSTRad9 
expressed in E.coli BL21-Codon Plus-RP strain is shown. 10µl of each collected 1ml fraction was loaded. 
Left side: Lanes: 1, low molecular weight markers; 2, uninduced cells, 3-8, culture induced at A600=1 with 
1mM IPTG, 1-6 hrs of induction; 9-14, culture induced at A600=1 with 0.5mM IPTG, 1-6 hrs of induction. 
Right side: Lanes: 1, low molecular weight markers; 2, uninduced cells, 3-8, culture induced at A600=1 
with 0.1mM IPTG, 1-6 hrs of induction. The position of the GSTRad9 band is indicated on the right. 
 
Figure 5B. MBPRad9 expression in E.coli BL21-Codon Plus-RP, pellets, Coomassie stained gel. A 
Coomassie blue-stained 10% SDS-polyacrylamide gel of the insoluble fractions (pellets) of MBPRad9 
expressed in E.coli BL21-Codon Plus-RP strain is shown. 10µl of each collected 1ml fraction was loaded. 
Left side: Lanes: 1, low molecular weight markers; 2, uninduced cells; 3-5, culture induced at A600=1 with 
0.5mM IPTG, 2,3 and 5 hrs of induction; 6-8, culture induced at A600=1 with 0.1mM IPTG, 2, 3 and 5 hrs 
of induction; 9-12, culture induced at A600=0.5 with 0.5mM IPTG, 2, 3, 5 and 7 hrs of induction. Right 
side: Lanes: 1, low molecular weight markers; 2, uninduced cells; 3-6, culture induced at A600=0.5 with 
0.1mM IPTG, 2, 3, 5 and 7 hrs of induction. The position of the MBPRad9 band is indicated by an arrow 
on the right. 
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Figure 5C. MBPRad9 expression in E.coli-TB1, pellets, Coomassie stained gel. A Coomassie blue-
stained 10% SDS-polyacrylamide gel of the insoluble fractions (pellets) of MBPRad9 expressed in E.coli –
TB1 strain is shown. 10µl of each collected 1ml fraction was loaded. Left side: Lanes: 1, low molecular 
weight markers; 2, uninduced cells; 3-5, culture induced at A600=1 with 0.5mM IPTG, 2, 3 and 5 hrs of 
induction; 6-8, culture induced at A600=1 with 0.1mM IPTG, 2, 3 and 5 hrs of induction; 9-12, culture 
induced at A600=0.5 with 0.5mM IPTG, 2, 3, 5 and 7 hrs of induction. Right side: Lanes: 1, low molecular 
weight markers; 2, uninduced cells, 3-6, culture induced at A600=0.5 with 0.1mM IPTG, 2, 3, 5 and 7 hrs 
of induction. The position of the MBPRad9 band is indicated by an arrow on the right. 
 
Figure 6A. GSTRad9 expression in E.coli BL21-Codon Plus-RP, protein-minipreparation, Coomassie 
stained gel. The soluble fractions of GSTRad9 expressed in E.coli BL21-Codon Plus-RP strain were 
incubated with washed and equilibrated Glutathione Sepharose 4B 50% slurry . Unbound protein was 
removed, Glutathione Sepharose 4B beads were washed and protein was eluted as described in Material 
and Methods. 25µl of the samples containing eluted protein were resolved by 12% SDS-PAGE and stained 
by Coomassie. Lanes: 1, low molecular weight markers; 2-7, culture induced at A600=1 with 1mM IPTG, 
1-6 hrs of induction. The position of the GSTRad9 band is indicated by an arrow on the right. 
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Figure 6B. MBPRad9 expression in E.coli BL21-Codon Plus-RP, protein-minipreparation, Coomassie 
stained gel. The soluble fractions of MBPRad9 expressed in E.coli BL21-Codon Plus-RP were incubated 
with washed and equilibrated amyloseresin 50% slurry. Unbound protein was removed, amylose-resin 
washed and protein eluted as described above. 25µl of the samples containing eluted protein were resolved 
by SDS-PAGE and stained by Coomassie. Left side: Lanes: 1, low molecular weight markers; 2, uninduced 
cells, 3-5, culture induced at A600=1 with 0.5mM IPTG, 2, 3 and 5 hrs of induction; 6-8, culture induced at 
A600=1 with 0.1mM IPTG, 2, 3 and 5 hrs of induction; Right side: Lanes: 1, low molecular weight 
markers; 2-4, culture induced at A600=0.5 with 0.5mM IPTG, 2, 5 and 7 hrs of induction; 5-8, culture 
induced at A600=0.5 with 0.1mM IPTG, 2, 3, 5 and 7 hrs of induction. The position of the MBPRad9 band 
is indicated by an arrow on the right. 
Figure 6C. MBPRad9 expression in E.coli-TB1, protein-minipreparation, Coomassie stained gel. The 
soluble fractions of each collected 1ml aliquot from the MBPRad9 expression in E.coli-TB1 were treated as 
described for Figure 6B. 25µl of the samples containing protein eluted from the beads were resolved by 
10% SDS-PAGE and stained by Coomassie. Left side: Lanes: 1, low molecular weight markers; 2, 
uninduced cells; 3-5, culture induced at A600=1 with 0.5mM IPTG, 2, 3 and 5 hrs of induction; 6-8, culture 
induced at A600=1 with 0.1mM IPTG, 2, 3 and 5 hrs of induction; Right side: Lanes: 1, low molecular 
weight markers; 2-5, culture induced at A600=0.5 with 0.5mM IPTG, 2, 3, 5 and 7 hrs of induction; 6-9, 
culture induced at A600=0.5 with 0.1mM IPTG, 2, 3, 5 and 7 hrs of induction. The position of the 
MBPRad9 band is indicated by an arrow on the right. 
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Figure 7A. GSTRad9 expression in E.coli BL21-Codon Plus-RP, supernatant, immunoblot analysis. 
20µl of the soluble part of GSTRad9 expressed in E.coli BL21-Codon Plus-RP were analysed by 12% SDS-
PAGE followed by immunoblot analysis using a α-GST polyclonal rabbit antibody. Left side: Lanes: 1, low 
molecular weight markers; 2, positive control GSTRad17; 3, negative control Aldolase; 4, uninduced cells; 
5-9, culture induced at A600=0.5 with 1mM IPTG, 2-6 hrs of induction; 10-12, culture induced at 
A600=0.5 with 0.5mM IPTG, 1-3 hrs of induction. Right side: Lanes: 1, low molecular weight markers; 2, 
uninduced cells; 3-5, culture induced at A600=0.5 with 0.5mM IPTG, 4-6 hrs of induction; 6-11, culture 
induced at A600=0.5 with 0.1mM IPTG, 1-6 hrs of induction. The GSTRad9 band is indicated on the right. 
Figure 7B. MBPRad9 expression in E.coli BL21-Codon Plus-RP, protein-minipreparation, 
immunoblot analysis. The fractions containing soluble expressed and bound MBPRad9 protein expressed 
in E.coli BL21-Codon Plus-RP were treated as described for Figure 6B. 25µl of the samples containing 
eluted protein were resolved by 10% SDS-PAGE and analysed by immunoblot analysis using a α-MBP 
polyclonal rabbit antibody. Left side: Lanes: 1, low molecular weight markers; 2, negative control 
GSTRad17; 3, negative control Aldolase; 4-6, culture induced at A600=1 with 0.5mM IPTG, 2, 3 and 5 hrs 
of induction; 7-9, culture induced at A600=1 with 0.1mM IPTG, 2, 3 and 5 hrs of induction. Right side: 
Lanes: 1, low molecular weight markers; 2, negative control; 3, negative control; 4, uninduced cells; 5-8, 
culture induced at A600=0.5 with 0.5mM IPTG, 2, 3, 5 and 7 hrs of induction; 9-12, culture induced at 
A600=0.5 with 0.1mM IPTG, 2, 3, 5 and 7 hrs of induction. The position of the MBPRad9 band is 
indicated by an arrow on the right, followed by the positive control MBPTrex2. 
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Figure 7C. MBPRad9 expression in E.Coli-TB1, protein-minipreparation, immunoblot analysis. The 
fractions containing soluble and bound MBPRad9 protein expressed in E.coli-TB1 were treated as 
described for Figure 6B. 25µl of the samples containing eluted protein were resolved by 10% SDS-PAGE 
and analysed by immunoblot analysis using a α-MBP polyclonal rabbit antibody. Left side: Lanes: 1, low 
molecular weight markers; 2, negative control GSTRad17; 3, negative control Aldolase; 4-6, culture 
induced at A600=1 with 0.5mM IPTG, 2, 3 and 5 hrs of induction; 7-9, culture induced at A600=1 with 
0.1mM IPTG, 2, 3 and 5 hrs of induction. Right side: Lanes: 1, low molecular weight markers; 2, negative 
control; 3, negative control; 4, uninduced cells; 5-8, culture induced at A600=0.5 with 0.5mM IPTG, 2, 3, 5 
and 7 hrs of induction; 9-12, culture induced at A600=0.5 with 0.1mM IPTG, 2, 3, 5 and 7 hrs of induction. 
The position of the MBPRad9 band is indicated by an arrow on the right, followed by a positive control 
MBPTrex2. 
 
3.2.5. Big culture and purification of MBPRad9 
3.2.5.1. Amylose-resin batch purification of MBPRad9 
pMalc-2E-Rad9 plasmid was transformed into E.coli BL21-Codon Plus-RP cells. A 
single colony was inoculated in LB medium and incubated overnight. Overnight culture 
was then added to flasks containing rich media and incubated to A600=1. IPTG was added 
to a final concentration of 0.5mM and the culture induced for 3 hrs at 27°C and 250 rpm. 
Aliquots were collected before (uninduced cells) and after (induced cells) induction. The 
cells were harvested by centrifugation and resuspended in lysis buffer. The bacteria were 
lysed by passage through a French press and the lysate was separated by centrifugation 
into a soluble (supernatant) and insoluble (pellet) fraction. The soluble fraction (load) was 
added to washed and equilibrated Amylose-resin slurry and rotated for several hours. 
After centrifugation, the supernatant was removed (unbound protein) and the Amylose-
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resin washed several times (wash). Bound recombinant MBPRad9 protein was then 
eluted six times with elution buffer by rotating each time for several minutes followed by 
centrifugation and collecting the supernatant (E1-E6). Load, unbound protein, wash and 
each collected fraction of eluted protein (E1-E6) were analysed by SDS-PAGE and 
Coomassie staining (Figure 8A).  
After this first purification step, a strong band with the predicted molecular mass of 85.4 
kDa, representing a high amount of soluble MBPRad9 recombinant protein could be 
found in the eluted fractions E1-E6 with decreasing amount of eluted MBPRad9 protein 
during the elution steps. Some MBPRad9 was also present in the unbound and wash 
fractions, showing the limited capacity of this batch purification system. Purified 
MBPRad9 recombinant protein was not that pure and showed a distinct second band at 
about 45 kDa representing either contamination or degraded MBPRad9 protein. 
According to these results a second purification step was added. Therefore the fractions 
E1-E6 containing MBPRad9 were pooled. The pI of MBPRad9 recombinant protein was 
calculated based on its codon sequence as described for GSTRad1. The pI of MBPRad9 
was 5.03 and therefore an anion exchange column was chosen as second purification step. 
 
3.2.5.2. Purification of MBPRad9 by an anion exchanger HiTrap Q  
The function of an anion exchanger is described above. An important parameter using 
this purification system is the pH chosen for the starting buffer. It should be, as described 
before, at least 1unit above the pI of the recombinant protein to be purified (pIMBPRad9= 
5.03). A lower pH would lead to an insufficient binding of the protein to the column, 
whereas a too high chosen pH could cause protein degradation. According to the fact that 
MBPRad9 has exactly the same calculated pI as GSTRad1, it was decided to choose the 
same pH for buffer A as used for GSTRad1 purification. So enrichment of recombinant 
MBPRad9 protein was achieved by pH 8 of buffer A, although the binding of GSTRad1 
to the anion exchanger was not sufficient using this pH (see above). But a pH above pH 8 
would likely cause protein degradation that would be very hard to separate from non-
degraded MBPRad9 as known from GSTRad1 purification. So the pooled fractions were 
dialysed against buffer A (load), and loaded onto the prepacked and equilibrated HiTrapQ 
 43 
anion exchange column as described above (see Materials and Methods) using a FPLC-
system. The flow through was saved and the column was washed several times, saving as 
well the washing fractions (wash). Bound MBPRad9 recombinant protein was then eluted 
with a continuous salt gradient elution and fractions were collected. Load, flow through 
and the collected fractions were analysed by SDS-PAGE and Coomassie staining (Figure 
8B). Most of the recombinant MBPRad9 protein eluted from the column between 
fractions 16-20, represented by a clear band at 85.4 kDa. The second band at about 45 
kDa, representing either degraded protein or contamination could be separated by this 
second purification step and eluted earlier from the anion exchanger column, mainly 
between fractions 11-14. A second band at about 60 kDa could not be separated properly 
and eluted  between fraction 17-23 from the column, a little bit later than most of 
MBPRad9 recombinant protein. Contrary to GSTRad1, it can be mentioned that the 
binding of MBPRad9 to the anion exchanger column was sufficient using a starting 
buffer with pH 8. No protein could be found in the flow through or washing fractions. 
Fractions 16-20 containing the main part of MBPRad9 recombinant protein were pooled 
to a main pool, Pool 1. Fractions 21-30 and 13-15 were pooled to two side pools, Pool 2 
and Pool 3, respectively. The protein content of each pool was quantified by Bradford 
assay (see Discussion, Table 10) and analysed by SDS-PAGE followed by subsequent 
Coomassie staining (Figure 8C). The pooled fractions were then dialysed against a 
storage buffer (see Materials and Methods), aliquoted and frozen at 80°C until further 
use (see Activity test, Figure 12). 
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Figure 8A. MBPRad9 purification, 1.6 l culture, Amylose-resin batch purification, Coomassie stained 
gel. The bacterial pellet of a 1.6 l culture of E.coli BL21-Codon Plus-RP expressing MBPRad9 was 
resuspended, lysed and separated into a soluble and insoluble fraction by centrifugation as described in 
Materials and Methods. Amylose-resin was washed, equilibrated and incubated with the soluble protein 
fraction. The unbound protein was removed, the resin washed, bound protein eluted six times and the 
supernatant containing purified MBPRad9 recombinant protein was collected (E1-E6). Saved aliquots of 
the load, the unbound protein, the wash and 10µl of each collected fraction E1-E6 were resolved by 10% 
SDS-PAGE and analysed by Coomassie staining. Lanes: 1, low molecular weight markers; 2, 1µl load: 3, 
1µl unbound protein; 4, 17.5µl wash; 5-10, 10µl of each eluted fraction E1-E6; 11, low molecular weight 
markers. The position of the MBPRad9 band is indicated by an arrow on the right. 
 
Figure 8B. MBPRad9 purification, anion exchange column HiTrap Q, Coomassie stained gel. The six 
eluted fractions E1-E6 from 8A. were pooled, dialysed and loaded onto a prepacked and equilibrated 
HiTrap Q anion exchange column as described in Materials and Methods. The column was washed, the 
protein eluted and 0.25ml fractions were collected. Aliquots of the load, flow through and 10µl of each 
collected 0.25ml fraction were analysed by 10% SDS-PAGE followed by Coomassie staining. Left side: 
Lanes: 1, low molecular weight markers; 2, 10µl load; 3, 10µl flow through; 4-15, 10µl of each fraction 9-
20 containing MBPRad9 protein eluted from the anion exchange column. Right side: Lanes: 1, low 
molecular weight markers; 2-15, 10µl of each fraction 21-34 containing MBPRad9 protein eluted from the 
anion exchange column. The position of the MBPRad9 band is indicated by an arrow on the right. 
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Figure 8C. MBPRad9 purification, Pool 1, Pool 2 and 
Pool 3 after two-step purification, Coomassie stained 
gel. After the anion exchange column HiTrap Q, fractions 
16-21, containing the main part of MBPRad9 were pooled 
to a main pool, Pool 1 and analysed by 10% SDS-PAGE 
followed by Coomassie staining. Two side pools, Pool 2 
and Pool 3, containing the fractions 22-30 and 13-15, 
respectively, were additionally analysed. Lanes: 1, 10µl of 
Pool 1; 2, 10µl of Pool 2; 3, 10µl of Pool 3; 4, low 
molecular weight markers. The position of the MBPRad9 
band is indicated by an arrow on the left. 
 
3.3. Hus1 
3.3.1. Fusion protein and expression conditions 
Among the numerous papers published on the function, structure and interactions of 
Hus1, only two of them describe bacterial expression of this human checkpoint protein 
(Table 3). Cai et al. used a pGEX-2TK expression vector leading to a GST-tagged fusion 
protein, GSTHus1 (Cai et al., 2000). For that purpose, the plasmid was transformed into 
bacteria and induced with IPTG. The precise bacterial strain and induction conditions 
used are not further described. The protein was purified by its binding to Glutathione 
Sepharose 4B beads and used for an in vitro GST pull-down assay to test its interaction 
with HDAC1, a histone deacetylase. In a second published paper that describes 
bacterially expressed recombinant Hus1 protein a pET24a+ expression vector was used to 
get (His)6-Hus1 which was then used to immunize rabbits (Volkmer and Karnitz, 1999). 
Bacterial strain, expression conditions, induction period and the solubility of purified 
(His)6-Hus1 were not further described. According to these data it was decided to test the 
expression of Hus1 as a GST-tagged fusion protein using a pGEX-expression vector as 
described for Rad1 and Rad9. Therefore Hus1 cDNA was amplified from pREP4-Hus1 
  MBPRad9 
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by PCR as described above (see Materials and Methods). The PCR product was then 
digested and inserted into pGEX-4T-3 to obtain the expression vector pGEX-4T-3-Hus1. 
3.3.2. Bacterial strain 
First of all the codon frequencies of GSTHus1, a 58 kDa protein, were checked to judge 
the problem of codon bias expressing this recombinant protein in E.coli (Table 8). 
 
Table 8. Codon frequencies of critical codons in GSTHus1 and E.coli 1 
Amino-acid Codon GSTHus1 E.coli 
arg AGG 5.9 1.4 
 AGA 5.9 2.1 
 CGA 7.9 3.1 
leu CTA 9.9 3.2 
ile ATA 15.7 4.1 
pro CCC 9.9 4.3 
 
1 Codon frequencies are expressed as codons used per 1,000 codons encountered. The two codon 
frequencies of GSTHus1 that differ most from E.coli are shown in bold to help identify a codon bias that 
may cause problems for high-level expression in E.coli. 
 
Focussing on the most critical codons like arg, leu, ile and pro, all of them are a little 
more frequently present in GSTHus1 than in originally expressed E.coli protein. The 
most distinct difference can be found in the arg codon AGG and the ile codon ATA so 
that the most reasonable E.coli strain to use for the expression of GSTHus1 would be 
E.coli BL21-Codon Plus-RIL, which contains extra copies of the argU, ileY and leuW 
tRNA genes. Nevertheless, these differences were never as significant as calculated for 
Rad9 or Rad1 recombinant protein (Tables 4, 6). Considering this fact it can be supposed 
that codon bias would probably not be the main obstacle for the expression of 
recombinant GSTHus1 protein in E.coli and it could therefore be reasonable to test 
additional strains, for example E.coli-TB1 or E.coli-TG1. Paying regard to their different 
genetic background it would thereby be possible to test its influence on the expression of 
soluble recombinant GSTHus1 protein (see Introduction and Problem). Therefore it was 
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decided to express GSTHus1 in three different E.coli strains: E.coli BL21-Codon Plus-
RIL, E.coli-TB1 and E.coli-TG1. 
 
3.3.3. Small scale cultures and solubility check of GSTHus1  
The three bacterial strains E.coli BL21-Codon Plus-RIL, E.coli-TB1 and E.coli-TG1 were 
tested under different conditions to find out how different IPTG-concentrations, various 
expression periods and induction at different cell densities would influence the expression 
level and solubility of recombinant GSTHus1 protein (Table 9). 
 
Table 9. Expression conditions tested for Hus1 
GSTHus1 in E.coli BL21-Codon Plus-RIL Expression conditions 
A600=1 1mM IPTG 
 0.5mM IPTG 
 0.1mM IPTG 
A600=0.5 1mM IPTG 
 0.5mM IPTG 
 0.1mM IPTG 
LB, 27°C 1h, 2h, 3h, 4h, 5h, 6h 
GSTHus1 in E.coli-TB1 Expression conditions 
A600=1 0.5mM IPTG 
 0.1mM IPTG 
A600=0.5 0.5mM IPTG 
 0.1mM IPTG 
LB, 27°C 1h, 3h, 5h 
GSTHus1 in E.coli-TG1 Expression conditions 
A600=1 0.5mM IPTG 
 0.1mM IPTG 
A600=0.5 0.5mM IPTG 
 0.1mM IPTG 
LB, 27°C 1h, 3h, 5h 
 
Small scale cultures and solubility check were done as described for GSTRad1 (see 
3.1.3.), collecting fractions every 1-2 hrs and thereby measuring A600 to test the toxicity 
of expressed GSTHus1 protein on the bacterial cells (data not shown). The insoluble 
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fractions were visualised by Coomassie stained gels (Figure 9), whereas the soluble 
fractions were analysed by SDS-PAGE followed by subsequent Coomassie staining (data 
not shown) or immunoblot analysis (Figure 10), respectively. 
3.3.3.1. GSTHus1 expressed in E.coli BL21-Codon Plus-RIL 
Considering the insoluble fraction (pellet) of the different expression conditions tested, a 
clear detectable band at the predicted molecular mass of 58 kDa could be identified on 
Coomassie stained gels representing GSTHus1 (Figure 9A). It got significantly stronger 
during the expression period, corresponding to the measured increase of A600 during 
expression (data not shown). On the other hand, considering the soluble fraction 
(supernatant) of GSTHus1 expressed in E.coli BL21-Codon Plus-RIL, no band could be 
identified at the predicted molecular mass, neither on Coomassie stained gel nor by 
immunoblot analysis (data not shown ). This leads to the conclusion that GSTHus1 is 
indeed expressed in E.coli BL21-Codon Plus-RIL at a reasonable level showing no 
manifest toxicity on the bacterial cells, but that the expressed protein is exclusively 
present in an insoluble form in the pellet forming so called inclusion bodies (see 
Introduction and Problem). They represent a denatured form of expressed protein which 
is therefore not suitable for any biochemical or structural studies. Therefore, the 
expression of recombinant GSTHus1 in E.coli BL21-Codon Plus-RIL was not further 
analysed. 
3.3.3.2. GSTHus1 expressed in E.coli-TB1 
Small scale cultures and solublity check were performed as described above, testing the 
different expression conditions written in Table 9. In contrast to the expression in E.coli 
BL21-Codon Plus-RIL, only the two lower IPTG concentrations (0.5mM IPTG, 0.1mM 
IPTG) were tested for E.coli-TB1 considering the fact that a low IPTG concentration 
causes a lower expression level of recombinant protein and can therefore be helpful to get 
a higher amount of soluble expressed protein (see Introduction and Problem). Looking at 
the insoluble fractions of GSTHus1 expressed in E.coli-TB1, a distinct band at the 
predicted molecular mass of 58 kDa could be found representing bacterially expressed 
GSTHus1 recombinant protein (Figure 9B). The expression level in E.coli-TB1 was even 
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better than detected for E.coli BL21-Codon Plus-RIL although the measured A600 wasnt 
significantly higher, suggesting that the expression capacity per cell seemed to be better 
in E.coli-TB1 than in E.coli BL21-Codon Plus-RIL. At this stage the soluble fractions of 
GSTHus1 expressed in E.coli-TB1 were compared. A clear band at about 58 kDa was 
detectable by immunoblot analysis (Figure 10A) representing soluble expressed 
GSTHus1 recombinant protein, whereas the second band at about 27 kDa likely 
represents GST-protein alone. This supposition is supported by the fact that this 27 kDa 
band gets distinctly stronger during the induction period. Additionally, it was evident that 
the amount of soluble expressed GSTHus1 protein was increased when the cells were 
induced at a lower cell density, supporting the thesis that a lower expression level could 
in fact lead to a higher amount of soluble protein (see Introduction and Problem). The 
expression condition chosen for an optimal bacterial expression of GSTHus1 in E.coli-
TB1 was A600=0.5, 0.5mM IPTG, 5 hrs of induction at 27°C. 
3.3.3.3. GSTHus1 expressed in E.coli-TG1 
The small scale cultures and solubility check were done as described above and the same 
expression conditions were tested for E.coli-TG1 as well as for E.coli-TB1 (Table 9). 
Comparing now the insoluble fractions (pellets) of expressed GSTHus1 in E.coli-TG1 
(Figure 9C) it can be summarized that the recombinant protein is expressed at a 
reasonable level comparable to E.coli BL21-Codon Plus-RIL, but at a lower level than in 
E.coli-TB1. Considering the soluble fractions (Figure 10B) it became clear that only very 
weak bands of expressed recombinant GSTHus1 at some expression conditions tested 
could be detected by immunoblot analysis. 
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Figure 9A. GSTHus1 expression in E.coli BL21-Codon Plus-RIL, pellets, Coomassie stained gels. A 
Coomassie blue-stained 12% SDS-polyacrylamide gel of the insoluble fractions (pellets) of GSTHus1 
expressed in E.coli BL21-Codon Plus-RIL strain is shown. 10µl of each collected 1ml fraction was loaded. 
Left side: Lanes: 1, low molecular weight markers; 2, uninduced cells; 3-8, culture induced at A600=1 with 
1mM IPTG, 1-6 hrs of induction; 9-14, culture induced at A600=1 with 0.5mM IPTG, 1-6 hrs of induction. 
Right side: Lanes: 1, low molecular weight markers; 2-7, culture induced at A600=1 with 0.1mM IPTG, 1-
6 hrs of induction. The position of the GSTHus1 band is indicated by an arrow on the right. 
 
Figure 9B. GSTHus1 expression in E.Coli-TB1, pellets, Coomassie stained gel. A Coomassie blue-
stained 12% SDS-polyacrylamide gel of the insoluble fractions (pellets) of GSTHus1 expressed in E.coli-
TB1strain is shown. 10µl of each collected 1ml fraction was loaded. Lanes: 1, low molecular weight 
markers; 2, uninduced cells; 3-5, culture induced at A600=1 with 0.5mM IPTG, 1, 3 and 5 hrs of induction; 
6-8, culture induced at A600=1 with 0.1mM IPTG, 1, 3 and 5 hrs of induction; 9-11, culture induced at 
A600=0.5 with 0.5mM IPTG, 1, 3 and 5 hrs of induction; 12-14, culture induced at A600=0.5 with 0.1mM 
IPTG, 1, 3 and 5 hrs of induction. The position of the GSTHus1 band is indicated by an arrow on the right. 
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Figure 9C. GSTHus1 expression in E.coli-TG1, pellets, Coomassie stained gel. A Coomassie blue-
stained 12% SDS-polyacrylamide gel of the insoluble fractions (pellets) of GSTHus1 expressed in E.coli–
TG1 strain is shown. 10µl of each collected 1ml fraction was loaded. Lanes: 1, low molecular weight 
markers; 2, uninduced cells; 3-5, culture induced at A600=1 with 0.5mM IPTG, 1, 3 and 5 hrs of induction; 
6-8, culture induced at A600=1 with 0.1mM IPTG, 1, 3 and 5 hrs of induction; 9-11, culture induced at 
A600=0.5 with 0.5mM IPTG, 1, 3 and 5 hrs of induction; 12-15, culture induced at A600=0.5 with 0.1mM 
IPTG, 1, 3 and 5 hrs of induction. The position of the GSTHus1 band is indicated by an arrow on the right. 
 
Figure 10A. GSTHus1 expression in E.coli-TB1, supernatants, immunoblot analysis. 20µl of the 
soluble fractions of each aliquot of GSTHus1 expressed in E.coli-TB1 was analysed by SDS-PAGE 
followed by immunoblot analysis using a α-GST polyclonal rabbit antibody. Lanes: 1, low molecular 
weight markers; 2-4culture induced at A600=1 with 0.5mM IPTG, 1, 3 and 5 hrs of induction; 5-7, culture 
induced at A600=1 with 0.1mM IPTG, 1, 3 and 5 hrs of induction; 8-10, culture induced at A600=0.5 with 
0.5mM IPTG, 1, 3 and 5 hrs of induction; 11-13, culture induced at A600=0.5 with 0.1mM IPTG, 1, 3 and 
5 hrs of induction; 14, uninduced cells; 15, negative control Aldolase; 16, positive control GSTRad17; 17, 
low molecular weight markers. The position of the GSTHus1 band is indicated by an arrow on the right. 
Degradation is indicated by  *. 
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Figure 10B. GSTHus1 expression in E.coli-TG1, supernatant, immunoblot analysis. The fractions were 
treated and analysed as described for 10A.. Lanes: 1, low molecular weight markers; 2, positive control 
GSTRad17; 3, negative control Aldolase; 4-6, culture induced at A600=1 with 0.5mM IPTG, 1, 3 and 5 hrs 
of induction; 7-9, culture induced at A600=1 with 0.1mM IPTG, 1, 3 and 5 hrs of induction; 10-12, culture 
induced at A600=0.5 with 0.5mM IPTG, 1, 3 and 5 hrs of induction; 13-15, culture induced at A600=0.5 
with 0.1mM IPTG, 1, 3 and 5 hrs of induction. The position of the GSTHus1 band is indicated by an arrow 
on the right. Degradation is indicated by  * . 
3.3.4. Optimised expression conditions for Hus1 
As a conclusion of all these data, it was evident that E.coli-TB1 was superior in 
expressing GSTHus1 recombinant protein in comparison to the two other E.coli strains 
tested. Using this strain, soluble and non-degraded protein could be found in every 
condition tested, although a lower cell density (A600=0.5) at the point of induction seemed 
to increase the level of soluble expressed GSTHus1 protein. The distinct second band 
detected, likely representing GST-protein alone, could probably be separated by a second 
purification step after Glutathione Sepharose 4B. Nevertheless, to get a reasonable 
amount of soluble purified GSTHus1 protein, a very large culture must be used for 
expression. Comparing the three checkpoint proteins Rad1, Rad9 and Hus1, this third 
human checkpoint protein seemed to be definitely the most difficult one to establish 
bacterial expression and purification because of its property to appear almost exclusively 
as inclusion bodies in the pellet. 
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3.3.5. Big culture and purification of GSTHus1 in E.coli-TB1 
3.3.5.1. Purification of GSTHus1 by a GSTrap column 
pGEX-4T-3-Hus1 plasmid was transformed in E.coli-TB1 cells following manufacturers 
instructions. A single transformed colony was inoculated in LB medium which was then 
expanded to a 4 l culture. At A600=0.5, IPTG was added to a final concentration of 
0.5mM and the culture was incubated at 27°C and 250 rpm for 5hrs. Aliquots were taken 
from uninduced and induced cells. After 5 hrs of induction the cells were harvested by 
centrifugation and resuspended in lysis buffer. Bacteria were lysed by passage through a 
French press and separated into a soluble (supernatant) and insoluble fraction (pellet) by 
centrifugation. The filtered soluble fraction was then applied to a prepacked and 
equilibrated GSTrap column using a FPLC-system. An aliquot of the load and the flow 
through was saved before the column was washed several times (wash). The bound 
GSTHus1 protein was eluted with elution buffer and fractions were collected. Load, flow 
through, wash and the collected fractions were analysed by SDS-PAGE and Coomassie 
staining (Figure 11A). Soluble GSTHus1 recombinant protein eluted mostly between 
fractions 5 14, detectable as a band at about 58 kDa. In addition to this 58 kDa form, a 
second distinct band was present at about 27 kDa. As described for the small scale 
cultures, this second band seemed to represent GST-protein alone, supported additionally 
by the fact that it clearly bound to Glutathione Sepharose 4B and eluted at the same 
fractions as GSTHus1 recombinant protein. Additionally, a third band was distinctly 
present just below the 58 kDa band, probably representing degraded GSTHus1 protein. 
This degraded protein was not present in the solubility check of the small scale cultures, 
probably indicating again that the purification of GST-tagged protein by its binding to 
Glutathione Sepharose 4B can lead to degradation. This degradation was also observed 
after the first purification step of GSTRad1, although no degraded protein was found in 
the analysed supernatant before purification. However, a second purification step of 
recombinant GSTHus1 protein was necessary. 
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3.3.5.2. Purification of GSTHus1 by an anion exchanger HiTrap Q 
The pI of GSTHus1 based on its codon sequence was calculated as pI=5.03. Therefore an 
anion exchanger HiTrap Q column was chosen as a second purification step as described 
for GSTHus1 and MBPRad9. For the starting buffer A pH=8 was selected to achieve a 
sufficient enrichment of target protein. Fractions 5-14 containing GSTHus1 recombinant 
protein were pooled and dialysed against buffer A before it was loaded onto the anion 
exchange column HiTrap Q using a FPLC-system. Bound protein was then eluted with a 
continuous salt gradient at an increase in ionic strength. Fractions were collected and 
load, flow through, wash and the collected fractions were analysed by SDS-PAGE and 
Coomassie staining (Figure 11B). The binding of GSTHus1 recombinant protein to the 
anion exchange column was sufficient and no target protein could be detected in the flow 
through and wash fraction. By this second purification step it was possible to remove the 
27 kDa band from the fractions containing the main part of GSTHus1. On the other hand, 
the second contaminating band just below the first 58 kDa band, likely representing 
degraded GSTHus1 protein, was not separated by this second column. Paying regard to 
the fact that these two bands eluted at exactly the same point from the column, it seemed 
to be impossible to separate them by an anion exchange column using different binding 
and elution conditions.  
The fractions 7, 8 and 9, containing most of purified GSTHus1 recombinant protein, were 
pooled to a main pool, Pool 1, whereas fractions 6,10,11 and 12-22 were pooled to two 
side pools, Pools 2 and Pool 3, respectively. The protein content of each pool was 
quantified by Bradford assay (see Discussion, Table 10) and analysed by SDS-PAGE 
followed by subsequent Coomassie staining (Figure 11C) or immunoblot analysis (data 
not shown), respectively. The pools were then dialysed against a storage buffer and 
frozen at 80°C until further use (see Activity test, Figure 12).  
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Figure 11A. GSTHus1 purification , 4 l culture, GSTrap column, Coomassie stained gel. The bacterial 
pellet of a 4 l culture of E.coli-TB1 expressing GSTHus1 was resuspended, lysed and the soluble fraction 
filtered as described in Materials and Methods. The filtered supernatant was applied to an equilibrated 
GSTrap column, followed by several washing steps. Bound GSTHus1 protein was eluted from the column 
as described above. 0.25ml fractions were collected and 1µl load, 1µl flow through , 1µl wash and 14µl of 
each collected fraction were resolved by 12% SDS-PAGE and analysed by Coomassie staining. Lanes: 1, 
low molecular weight markers; 2, load; 3, flow through; 4, wash; 5-15, 14µl of each fraction 4-14 
containing GSTHus1 protein eluted from the GSTrap column. The position of the GSTHus1 band is 
indicated by an arrow on the right. 
 
Figure 11B. GSTHus1 purification, anion exchange column HiTrap Q, Coomassie stained gel. Pooled 
and dialysed fractions containing the main part of GSTHus1 after GSTrap were loaded onto a prepacked 
and equilibrated HiTrap Q anion exchange column as described in Materials and Methods. After several 
washing steps, the protein was eluted and 0.25ml fractions were collected. Aliquots of the load, flow 
through and wash were analysed together with 10µl of each collected 0.25ml fraction by 12% SDS-PAGE 
followed by Coomassie staining. Left side: Lanes: 1, low molecular weight markers; 2, 10µl load; 3, 10µl 
flow through; 4, 10µl wash; 5-15, 10µl of each fraction 1-11 containing GSTHus1 protein eluted from the 
anion exchange column. Right side: Lanes: 1, low molecular weight markers; 2-15, 10µl of each fraction 
12-25 containing GSTHus1 protein eluted from the anion exchange column. The position of the GSTHus1 
band is indicated by an arrow on the right. 
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Figure 11C. GSTHus1 purification, Pool 1, Pool 2 and Pool 3 
after two-step purification, Coomassie stained gel. After the 
anion exchange column HiTrap Q, fractions 7-9, containing the 
main part of GSTHus1 were pooled to a main pool, Pool 1 and 
analysed by 12% SDS-PAGE followed by Coomassie staining. 
Two side pools, Pool 2 and Pool 3, containing the fractions 6, 10, 
11 and 12-22, respectively, were additionally analysed. Lanes: 1, 
10µl of Pool 1; 2, 10µl of Pool 2; 3, 10µl of Pool 3; 4, low 
molecular weight markers. The position of the GSTHus1 band is 
indicated by an arrow on the left. 
 
 
3.4. Activity test of purified GSTRad1, MBPRad9 and GSTHus1  
After having optimised the expression conditions for Rad1, Rad9 and Hus1 in small scale 
cultures and the expression and purification of a reasonable amount of soluble protein in 
a large scale culture it was important to prove that all three purified recombinant proteins 
were properly folded. As described earlier (see Introduction and Problem), molecular 
modelling studies support the thesis that Rad9, Rad1 and Hus1 form a heterotrimeric ring 
similar to PCNA (Figure 1). In later experiments, Rad9, Rad1 and Hus1 have been shown 
to interact by yeast-two-hybrid analysis and immunoprecipitation (Caspari et al., 2000; 
Hang and Lieberman, 2000; St Onge et al., 1999; Volkmer and Karnitz, 1999). Based on 
these data, functional activity of the three checkpoint proteins could thereby be proved by 
testing their direct interaction in vitro. Dot blot Far Western analysis was therefore 
performed to determine whether purified recombinant MBPRad9 and GSTHus1 or 
MBPRad9 and GSTRad1, respectively, showed direct and specific interaction in vitro. 
Essentially, this procedure involves the immobilisation of one of the proteins of interest 
to a nitrocellulose filter which is then incubated in buffer containing the second protein. 
The filter is washed to remove any unbound material and the presence of the second 
protein is detected by conventional Western analysis. 
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As a first step, three increasing amounts of purified MBPRad9 protein were dotted onto a 
nitrocellulose filter. Additionally, wtPCNA and MBPTrex2 used as negative controls and 
GSTRad17 and GSTHus1 as positive controls were immobilised on the same 
nitrocellulose filter. The nitrocellulose filter was dried on air, then rehydrated in aqua 
bidest and finally incubated with either purified GSTHus1 or GSTRad1. Conventional 
Western analysis was then used to detect the presence of GSTHus1 or GSTRad1 using α-
GST polyclonal antibody (Figure 12).  
When GSTHus1 was used to probe MBPRad9 bound to nitrocellulose, three 
immunoreactive dots of increasing size could be detected at the position where MBPRad9 
had been immobilised. This was due to Hus1 binding to Rad9, as opposed to 
crossreactivity of α-GST antibody with MBPRad9, because this dot was absent on a 
control blot with immobilised GSTRad17, MBPTrex2 and MBPRad9 that had been 
incubated in TBS without Hus1 or Rad1, respectively, but had otherwise been treated in 
the same way. The interaction between Hus1 and Rad9 appeared to be specific because 
Hus1 did not bind to either of two control proteins, MBPTrex2 and wtPCNA, which were 
immobilised in parallel on the same blot. The same experiment was carried out wherein 
GSTRad1 was used to probe nitrocellulose-bound MBPRad9. Three immunoreactive dots 
of increasing size could again be detected at the position where MBPRad9 had been 
immobilised. This interaction between Rad1 and Rad9 also seemed to be specific because 
Rad1 did not bind to either of the two control proteins MBPTrex2 and wtPCNA, which 
were immobilised on the same blot. It can be concluded that the purified recombinant 
Rad9, Hus1 and Rad1 were most likely properly folded since they could interact with 
each other in a so called Dot blot Far Western analysis (Figure 12), suggesting that they 
might be functionally expressed in the bacterial expression systems used in this study. 
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Figure 12. Interaction of purified Rad9, Rad1 and Hus1 in vitro. Three increasing amounts of purified 
MBPRad9 protein were dotted onto a nitrocellulose filter. wtPCNA and MBPTrex2, used as negative 
controls and GSTRad17 and GSTHus1 as positive controls were immobilised on the same nitrocellulose 
filter. The filter was dried on air, rehydrated and incubated with either purified GSTHus1 or GSTRad1. 
Conventional Western blot analysis was used to detect the presence of GSTHus1 or GSTRad1 using α-GST 
polyclonal antibody. Three immunoreactive dots of increasing size could be detected at the position where 
MBPRad9 have been immobilised, due to Rad9 binding to Hus1 or Rad1, respectively. Left blot: Lane 1: 
3µg, 5µg and 7µg of purified MBPRad9 recombinant protein. Lane 2: 2µl GSTRad17, 3µl wtPCNA, 2µl 
MBPTrex2; 0.5µg GSTHus1. Middle blot: Lane 1: 2µl GSTRad17, 3µl wtPCNA, 2µl MBPTrex2; 2µl 
GSTRad1. Lane 2: 3µg, 5µg and 7µg of purified MBPRad9 recombinant protein. Control blot: 2µl 
GSTRad17, 2µl MBPTrex2, 3µg MBPRad9. 
  
4. Discussion 
4.1. Optimised bacterial expression of Rad1 
Among the three checkpoint proteins analysed, Rad1 appeared to be the most suitable for 
its expression in E.coli, although only very little data is so far published on bacterial 
expression of recombinant Rad1 protein. Expressing it as a GST-fusion protein resulted 
in very good yields of soluble protein (Table 10). According to the distinct differences 
between the codon frequencies of GSTRad1 and E.coli (Table 4), the expression in 
special E.coli BL21-Codon Plus-RIL strains seemed to be reasonable and resulted in high 
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yields of expression in every condition tested. Thereby, a time-course analysis of the 
expression level used to check the soluble and insoluble fractions showed indeed that 
GSTRad1 was mainly expressed as an insoluble form, but that about 25% of the 
expressed protein was nevertheless present in the soluble fractions. This soluble protein 
expressed was moreover present in a non-degraded form and at a constant level during 
the induction period. Thereby, the different expression conditions and the various 
induction periods tested showed no distinct differences in the expression level of soluble, 
non-degraded protein. On the other hand, it could be shown by protein-minipreparation 
that the soluble GSTRad1 recombinant protein was able to bind to Glutathione Sepharose 
4B, but thereby showed some degradation which got clearly stronger during the induction 
period. According to these results, GSTRad1 was expressed in E.coli BL21-Codon Plus-
RIL in a large scale culture. Therefore, a short induction period (3 hrs), a high 
concentration of IPTG (1mM) and a high cell density at the time of induction (A600 =1) 
was chosen resulting in a short but high level protein expression with less degradation. 
The purification of this large-scale culture in two steps using a GSTrap and an anion 
exchange column led to a reasonable amount of 1.3mg/ml soluble purified GSTRad1 
recombinant protein (Table 10), although the conditions chosen for the anion exchanger 
HiTrap Q did not result in a sufficient binding of GSTRad1 to the column and need to be 
optimised. Finally, the purified Rad1 recombinant protein was shown to interact directly 
with Rad9 in vitro and therefore appeared to be properly folded. 
4.2. Optimised bacterial expression of Rad9 
Comparing the data published on the three checkpoint proteins, Rad9 seemed to be the 
best characterized one and numerous papers exist about its function, structure and 
interaction with other proteins. Therefore, two published papers could be taken as basis 
for the experiments that mentioned bacterially expressed MBPRad9 and GSTRad9 
recombinant protein in functional assays but without any details about the precise 
bacterial strain and expression conditions used (Schwartz et al., 2002; Bessho and Sancar, 
2000). Considering the distinct differences between the codon frequencies of Rad9 fusion 
proteins and E.coli, this checkpoint protein was very suitable for its expression in E.coli 
BL21-Codon Plus-RP strain. Testing additionally a conventional E.coli-TB1 strain, the 
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expression level and the solubility of expressed recombinant protein could be compared. 
Using a time-course analysis to check the expression level of the soluble and insoluble 
fraction at various times after induction, it was shown that the bacterial expression of 
Rad9 as a MBP-fusion protein was clearly superior to its expression as a GST-fusion 
protein. This confirms the results of earlier systematic comparisons of different fusion 
partners in increasing the solubility of passenger polypeptides (Kapust and Waugh, 
1999). It was thereby found that MBP was far superior to either thioredoxin or 
Glutathione-S-transferase (GST) as a solubilizing partner. In our studies, it was 
additionally shown that not only the solubilizing effect was obvious but also the 
expression level could be clearly increased. At this point, the ability of the two strains 
E.coli BL21-Codon Plus-RP and E.coli-TB1 in expressing MBPRad9 recombinant 
protein was compared. The expression level and the amount of soluble protein expressed 
in E.coli BL21-Codon Plus-RP was far superior to E.coli-TB1, although exactly the 
opposite was observed for GSTHus1. This could be due to the fact that the high number 
of pro codons CCC in the codon sequence of Rad9 plays in fact a critical role. This so 
called codon bias seemed to be a distinct obstacle for the efficient expression of 
recombinant Rad9 protein in E.coli. Therefore, the expression of soluble recombinant 
MBPRad9 protein can be clearly increased using E.coli BL21-Codon Plus-RP strains. 
Finally, when comparing the time-course analysis and the different expression conditions 
tested, it can be summarized that a high cell density at the time of induction (A600 =1), a 
quite high IPTG concentration (0.5mM) and a short induction period (3hrs) was able to 
minimize protein degradation. Using these optimised expression conditions for a large-
scale culture followed by a two step purification, an amount of 0.99mg/ml soluble 
purified MBPRad9 protein was reached (Table 10). Thereby, the described amylose-resin 
batch purification was shown to bind a high amount of soluble MBPRad9 protein, 
although the purity of bound MBPRad9 after this first purification step was not sufficient. 
On the other hand, a second purification step using an anion exchange column HiTrap Q 
could clearly separate some contamination and thereby increased the amount of 
homogeneous and soluble MBPRad9 protein. Although further purification steps could be 
required, the most likely proper folding of Rad9 after these two steps of purification was 
shown by its direct and specific interaction with Hus1 and Rad1 in vitro. 
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4.3. Optimised bacterial expression of Hus1 
As opposed to Rad9, only little data is published on Hus1 which seemed to be the least 
characterized of the three checkpoint proteins examined. Nevertheless published data was 
available on bacterially expressed GSTHus1 protein used for a functional assay that could 
be taken as a basis for our further experiments (Cai et al., 2000). Contrary to Rad1 and 
Rad9, Hus1 does not have such different codon frequencies as compared to E.coli 
focussing on the critical codons for its bacterial expression. Therefore, two conventional 
strains, E.coli-TB1 and E.coli-TG1, were tested in addition to E.coli BL21-Codon Plus-
RIL paying regard to the influence of a different genetic background on the level of 
soluble expressed recombinant protein. Considering the differences between the bacterial 
expression of GSTHus1 protein in these three strains, different expression levels were in 
fact found, indicating that E.coli-TB1 is clearly superior in expressing high yields of 
recombinant GSTHus1 and additionally high amounts of soluble protein. The observation 
that E.coli–TB1 shows better yields of soluble GSTHus1 recombinant protein than the 
special E.coli BL21-Codon Plus-RIL strain could indicate that codon bias is not the main 
obstacle to express this checkpoint protein, which corresponds with the fact that the 
codon frequencies of GSTHus1 are not such different as compared to E.coli. For the 
efficient bacterial expression of soluble Hus1 recombinant protein other parameters 
seemed to play a critical role, such as different expression conditions or different fusion 
partners. Considering the time course analysis and the different expression conditions 
tested for GSTHus1 expressed in E.coli-TB1 the amount of soluble protein seemed to be 
increased at a lower cell density at the time of induction (A600 =0.5). This supports the 
thesis that a lower expression level can lead to a higher amount of soluble expressed 
recombinant protein. Nevertheless, it must be mentioned that even with these optimised 
conditions, GSTHus1 was expressed mostly insoluble and formed inclusion bodies. After 
the expression of GSTHus1 in a large-scale culture using the optimised conditions 
established and the following two steps of purification an amount of 0.043mg/ml soluble 
and purified GSTHus1 protein was reached which was far below the amount expressed 
for Rad1 and Rad9 (Table 10). Thereby, some degradation was still present after the 
second column and appeared to be difficult to separate by further purification steps. 
Nevertheless, this purified form of recombinant Hus1 protein was shown to be most 
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likely properly folded by its specific binding to Rad9 in vitro and should thereby be 
suitable for further biochemical or structural studies. It can be assumed that expressing 
Hus1 as a different fusion protein results in higher amounts of soluble expressed 
recombinant protein. Therefore, it could be reasonable to test additional fusion partners, 
primarily MBPHus1 fusion protein, to find out if Hus1 could be bacterially expressed in 
higher yields and still shows functional activity. 
 
Table 10. Yields of GSTRad1, MBPRad9 and GSTHus1 recombinantly produced in 
E.coli 1 
Protein mg/ml 2 ml 2 mg total 2 mg/l culture 3 
GSTRad1 1.33 1.3 1.73 0.975 
MBPRad9 0.997 1.4 1.40 1.21 
GSTHus1 0.043 0.75 0.032 0.011 
 
1  the protein amount was quantified by Bradford assay 2 only the main pool was included 3 all pools were 
included 
4.4. Conclusion 
During this thesis it became clear that optimised bacterial expression of a recombinant 
protein depends on numerous parameters that can be individually varied. Therefore the 
conditions for optimised expression of a specific protein have to be established 
empirically. According to the experiments performed with Rad9, MBP was far superior 
to glutathione-S-transferase as a solubilizing partner and showed higher yields of 
expression. Additionally E.coli BL21-Codon Plus strains could in fact improve the 
expression level of some special recombinant proteins. Thereby it must be checked if 
codon bias is likely to be a main obstacle for the expression of this protein by calculating 
its codon frequencies. In other cases, such as Hus1, codon bias does not play that critical 
role and other E.coli strains with different genetic background can be superior in its 
expression. Therefore, a time-course analysis testing different expression conditions by 
small-scale cultures seemed to be indispensable for establishing optimised expression 
conditions for each individual protein. Thereby, good yields of soluble, homogeneous and 
properly folded protein can be reached by bacterial expression systems. 
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5. Summary 
The human checkpoint proteins Rad9, Rad1 and Hus1 are three DNA quality control 
proteins that play a critical role in cell cycle checkpoint signalling pathways. These 
checkpoints are activated due to DNA damage, slow down cell cycle progression and 
coordinate DNA repair. Failure of this cell cycle surveillance mechanism can cause 
genomic instability which could eventually lead to cancer formation in mammals. 
Soluble and functionally active proteins are required for biochemical and structural 
analysis of Rad9, Rad1 and Hus1. It is known that these three checkpoint proteins are 
extraordinarily difficult to express in E.coli and only little and incomplete data was 
collected on their bacterial expression. In this thesis different E.coli-strains were used 
focussing on special E.coli BL21-Codon Plus strains, which selectively express certain 
amino-acids in abundance. Furthermore, different fusion partners and expression 
conditions were tested for each individual checkpoint protein in order to empirically 
establish optimised expression conditions. It was shown that soluble and properly folded 
Rad1 can be expressed in good yields as a GST-tagged protein using the E.coli BL21-
Codon Plus-RIL strain if optimised expression conditions were established. For Rad9 the 
best yield of soluble expressed protein was found as a MBP-tagged protein using the 
E.coli BL21-Codon Plus-RP strain. A reasonable amount of soluble recombinant 
MBPRad9 was purified and shown to be properly folded by its direct and specific 
interaction with Rad1 and Hus1 in vitro. Hus1 was found to be the most insoluble of the 
three checkpoint proteins analysed. Despite this property, a certain amount of GSTHus1 
was bacterially expressed in E.coli-TB1 in a soluble and properly folded form. 
Nevertheless, the bacterial expression of Hus1 needs to be further optimised and 
additional fusion partners need to be tested. In summary, E.coli BL21-Codon Plus strains 
are a suitable system for the production of the two checkpoint proteins Rad1 and Rad9, 
and to some extent also of Hus1, which can be functionally and biochemically tested. 
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6. Zusammenfassung 
Die drei Checkpoint-Proteine Rad9, Rad1 und Hus1 spielen eine wichtige Rolle bei der 
Kontrolle der replizierten DNA an Kontrollpunkten (checkpoints) des Zellzyklus. Diese 
werden als Folge eines DNA-Schadens aktiviert, verlangsamen oder stoppen die DNA-
Replikation und koordinieren die DNA-Reparaturmechanismen. Wenn diese 
Kontrollmechanismen der Zelle versagen, kann dies zur Instabilität des Genoms führen 
und damit letzten Endes zur Entwicklung von Krebs beitragen. 
Für biochemische Untersuchungen und Strukturanalysen von Rad9, Rad1 und Hus1 sind 
lösliche und funktionell aktive Proteine erforderlich. Es ist jedoch bekannt, dass diese 
drei Checkpoint-Proteine in E.coli ausserordentlich schwierig zu exprimieren sind und 
bisher nur wenige und unvollständige Daten darüber publiziert wurden. Im Rahmen der 
vorliegenden Dissertation wurden verschiedene E.coli Stämme getestet, wobei 
hauptsächlich spezielle E.coli BL21-Codon Plus Stämme zum Einsatz kamen, welche 
gewisse Aminosäure-Codons in einem hohen Masse exprimieren. Ausserdem wurden 
unterschiedliche Fusionspartner und Expressionsbedingungen für die einzelnen 
Checkpoint-Proteine getestet, um auf empirischem Weg optimale Bedingungen für deren 
bakterielle Produktion zu etablieren. Es konnte gezeigt werden, dass Rad1 als GST-
Fusionsprotein in E.coli BL21-Codon Plus-RIL Stämmen bei optimierten 
Expressionsbedingungen in löslicher und richtig gefalteter Form und in ausreichender 
Menge exprimiert werden kann. Rad9 konnte als MBP-Fusionsprotein in E.coli BL21-
Codon Plus-RP Stämmen in löslicher Form und genügender Menge hergestellt werden. 
Seine korrekte Faltung wurde durch die spezifische und direkte Interaktion mit Rad1 und 
Hus1 in vitro gezeigt. Hus1 scheint das am wenigsten lösliche der drei getesteten 
Checkpoint-Proteine zu sein. Trotz dieser Eigenschaft konnte eine gewisse Menge an 
löslichem und richtig gefaltetem Protein als GSTHus1 in E.coli-TB1 hergestellt werden. 
Trotzdem muss die bakterielle Expression von Hus1 noch verbessert werden, indem man 
weitere Fusionspartner untersucht. Zusammenfassend kann ausgesagt werden, dass E.coli 
BL21-Codon Plus Stämme sich eignen, um genügende Mengen der zwei Checkpoint-
Proteine Rad1 und Rad9, sowie in beschränktem Ausmass Hus1 zu isolieren, um diese 
biochemisch und funktionell testen zu können. 
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